fibrinogen has been researched along with Hypercoagulability in 220 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (1.36) | 18.7374 |
| 1990's | 15 (6.82) | 18.2507 |
| 2000's | 86 (39.09) | 29.6817 |
| 2010's | 74 (33.64) | 24.3611 |
| 2020's | 42 (19.09) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Lu, H; Tang, S; Yu, W | 1 |
| Abell, T; Bills, G; Kedar, A; Pinkston, C; Rock, WA; Sarker, S; Seabrook, N | 1 |
| Margolin, E; Nicholson, P; Patel, TJ; Zaslavsky, K | 1 |
| Ataullakhanov, FI; Balandina, AN; Balatskiy, AV; Ignatova, AA; Kobalava, ZD; Koltsova, EM; Kotova, EO; Panteleev, MA; Pisaryuk, AS; Polokhov, DM; Povalyaev, NM; Sorokina, MA | 1 |
| Abderraouf, O; Ajmi, C; Amene, BB; Amina, B; Elaa, A; Haifa, M; Houyem, SL; Syrine, C; Walid, N | 1 |
| Andrianova, IA; Ataullakhanov, FI; Evtugina, NG; Khabirova, AI; Litvinov, RI; Peshkova, AD; Rumyantsev, AG; Safiullina, SI; Sannikova, SS; Tarasova, GR | 1 |
| Božič Mijovski, M; Jug, B; Košuta, D; Novaković, M | 1 |
| Bargoud, CG; Gosselin, AR; Hanna, JS; Tutwiler, V; White, NJ | 1 |
| Ayata, R; Esaki, Y; Fujita, M; Harada, K; Kaneda, K; Koga, Y; Shin, M; Tsuruta, R; Yagi, T | 1 |
| Kirsch-Altena, A; Müller, J; Sachs, UJ | 1 |
| Dai, SM; Wang, Q | 1 |
| Cohen, MJ; Coleman, JR; Dow, N; Freeman, K; Hansen, K; Moore, EE; Schmitt, L; Silliman, CC | 1 |
| Donskay, Y; Kryachkova, N; Loskutova, T; Petulko, A | 1 |
| Bui-Thi, HD; Le Minh, K | 1 |
| Bui, TD; Bui-Thi, HD; Le, MK; Nguyen, DK; Nguyen, MD; To, GK; Tran, H | 1 |
| Chen, J; Chen, Q; Fang, Z; Gong, Z; Kong, W; Li, G; Liu, D; Rao, X; Xu, C; Zhao, Y | 1 |
| Castle, J; Descamps, T; Kirwan, CC | 1 |
| Cancio, LC; Dubick, MA; Holcomb, JB; Martini, WZ; Pusateri, AE; Wolf, SE; Yu, YM | 1 |
| Duque, P; Levy, JH; Mora, L; Schöchl, H | 1 |
| Du, X; Fang, M; Han, Y; Lai, R; Li, Y; Lu, Q; Mwangi, J; Tang, X; Wang, G; Wang, S; Wu, J; Xue, M; Yang, B; Zhang, L; Zhang, Z | 1 |
| Biedermann, JS; de Maat, MPM; Kruip, MJHA; Leebeek, FWG; Lijfering, WM; Rijken, DC; Schol-Gelok, S; van der Meer, FJM; van Gelder, T; Versmissen, J | 1 |
| Boscolo, A; Campello, E; Cerruti, L; Navalesi, P; Poletto, F; Simioni, P; Spiezia, L; Tiberio, I | 1 |
| Chiba, M; Fujino, T; Hamada, A; Koga, T; Mitsudomi, T; Nishino, M; Ohara, S; Sato, K; Shimoji, M; Soh, J; Suda, K; Takemoto, T; Tomizawa, K | 1 |
| Levi, M; Thachil, J | 1 |
| Avşar, A; Dural, İE; Emren, SV; Onrat, E; Tutgun Onrat, S; Yalım, Z | 1 |
| Chow, JH; Galvagno, S; Grazioli, A; Herr, D; Madathil, R; Mazzeffi, M; Menaker, J; Menne, A; Rabin, J; Scalea, T; Tabatabai, A; Tanaka, K | 1 |
| Thachil, J | 1 |
| Ahmed, S; Gasparyan, AY; Zimba, O | 1 |
| Benoit, JL; Benoit, SW; Favaloro, EJ; Henry, BM; Hoehn, J; Lippi, G | 1 |
| Chow, JH; Mazzeffi, MA; Tanaka, K | 1 |
| Besser, M; Bridgeman, C; Cox-Morton, S; Duff, E; Edwards, T; Hayman, M; Kirk, M; MacDonald, S; Mahajan, S; Moore, C; Sharp, M; Thomas, W; White, D; Williams, R | 1 |
| Hadi, TK; Mohammad, NS; Nooruldin, SA | 1 |
| Bjørnvad, CR; Krogh, AKH; Lyngby, JG; Nielsen, LN | 1 |
| Sharma, M; Surani, S | 1 |
| Andreotti, F; De Cristofaro, R; Lancellotti, S; Liuzzo, G; Pedicino, D; Sacco, M | 1 |
| Antic, D; Bukumiric, Z; Cvetkovic, Z; Fareed, J; Libek, V; Milenkovic, B; Milosevic, I; Mitrovic, M; Pantic, N; Pravdic, Z; Sabljic, N; Savic, N; Suvajdzic, N; Virijevic, M; Vucinic, V; Zivkovic Dakic, A | 1 |
| Bade, N; Chandel, A; Khangoora, V; King, CS; Looby, M; Patolia, S | 1 |
| Marco, A; Marco, P | 1 |
| Fukuda, T; Ichikawa, J; Ishikawa, M; Komori, M; Okazaki, R; Ono, T | 1 |
| Devreese, KMJ | 1 |
| Bliden, KP; Cho, A; Gurbel, PA; Jerjian, C; Levy, JH; Rapista, N; Tantry, US; Walia, N | 1 |
| Altschul, D; Benton, J; Boehme, AK; Cheng, NT; Dardick, J; Esenwa, C; Fernandez-Torres, J; Flomenbaum, D; Frontera, J; Goldman, I; Holland, R; Ishida, K; Kirchoff-Torres, K; Labovitz, D; Lendaris, A; Liberman, AL; Lord, A; Lu, J; Luna, J; Mabie, P; Malaviya, A; Moncrieffe, K; Patel, N; Seiden, J; Snyder, T; Soetanto, A; Toma, A; Torres, J; Willey, J; Yaghi, S | 1 |
| Gudaityte, R; Kupcinskas, J; Kupcinskiene, K; Macas, A; Maleckas, A; Petereit, R; Trepenaitis, D | 1 |
| Burkhard, MJ; Byron, JK; Dudley, A; Guillaumin, J; Warry, E | 1 |
| Bushueva, O; Churnosov, M; Dvornyk, V; Krikun, E; Orlova, V; Polonikov, A; Reshetnikov, E; Zarudskaya, O | 1 |
| Banerjee, A; Burlew, CC; Chapman, MP; Moore, EE; Moore, HB; Nunns, GR; Peltz, E; Sauaia, A; Silliman, CC; Stettler, GR | 1 |
| Feng, C; Gao, L; Guo, X; Wang, Q; Wang, Z; Wu, Y; Xing, B; Xu, Z; Yang, Y; Zhang, F | 1 |
| Cardenas, JC; Cotton, BA; George, MJ; Holcomb, JB; Schreiber, MA; Wade, CE; White, NJ | 1 |
| Ala-Kokko, T; Erkinaro, T; Koivukangas, V; Laurila, P; Ohtonen, P; Savolainen, ER; Tuovila, M | 1 |
| Baumbusch, LO; Bokiniec, R; Borszewska-Kornacka, MK; Bujak-Gizycka, B; Kwinta, P; Madej, J; Madetko-Talowska, A; Pietrzyk, JJ; Revhaug, C; Saugstad, OD; Suski, M; Szwarc-Duma, M; Zasada, M | 1 |
| Ataullakhanov, FI; Bondar, EV; Poletaev, AV; Seregina, EA; Smetanina, NS; Vuimo, TA | 1 |
| Caldwell, SH; Greenberg, CS; O'Leary, JG; Patton, HM | 1 |
| Campello, E; Ilich, A; Key, NS; Simioni, P | 1 |
| Bolad, I; Breall, JA; Flockhart, DA; Kreutz, RP; Lu, D; Owens, J; Sinha, A; von der Lohe, E | 1 |
| Cerin, E; Dunstan, DW; Fraser, SF; Hamilton, MT; Howard, BJ; Kingwell, BA; Owen, N; Sethi, P | 1 |
| Kawai, K; Watanabe, T | 1 |
| Belaj, K; Brodmann, M; Bruckenberger, R; Froehlich, H; Gary, T; Hackl, G; Hafner, F; Pilger, E; Zebisch, A | 1 |
| Chaparzadeh, N; Farzadi, L; Ghasemzadeh, A; Ghorbian, S; Kafshdooz, T; Poursadegh Zonouzi, A; Sadaghiani, MM; Sakhinia, E; Sakhinia, M | 1 |
| Baranov, DA; Gusev, VV; Kuznetsov, NN; Lvova, OA; Partylova, EA; Voroshilina, ES | 1 |
| Dyr, JE; Geierová, V; Kotlín, R; Májek, P; Riedel, T; Riedelová-Reicheltová, Z; Suttnar, J | 1 |
| Hilhorst, M; ten Cate, H; Tervaert, JW; van Oerle, R; Wilde, B; Winckers, K | 1 |
| Ancelin, ML; Brailly-Tabard, S; Carcaillon, L; Dartigues, JF; Guiochon-Mantel, A; Rouaud, O; Scarabin, PY | 1 |
| Andersen, MG; Hvas, AM; Hvas, CL; Tønnesen, E | 1 |
| Galligan, A; McMichael, MA; Smith, SA; Swanson, KS | 1 |
| Dorđević, V; Miljić, P; Nedeljkov-Jančić, R; Subota, V; Zuvela, M | 1 |
| Galli-Tsinopoulou, A; Giza, S; Kotanidou, EP; Kyrgios, I; Maggana, I; Mouzaki, K; Papadakis, E; Stergidou, D | 1 |
| Frank, RD; Risse, F; Weinberger, AW | 1 |
| Anderson, CD; Anderson, SG; Cruickshank, JK; Heald, AH; Hutchings, DC; Sanders, TA | 1 |
| Aizezi, R; Chen, Y; Upur, H; Zhong, M | 1 |
| Ababneh, OH; Abu-Ameerh, MA; Al-Khateeb, MA; Albdour, MD; Awidi, AS; Awidi, MA; Bener, A; Dweik, MR; Gharaibeh, AM; Saleh, MM | 1 |
| Markin, AV; Petukhova, NL; Schigoleva, AV; Tsaturova, KA; Vartanian, EV | 1 |
| Kell, DB; Pretorius, E | 1 |
| Cui, L; Hong, L; Li, Y; Wang, C; Wang, J; Wei, S | 1 |
| Afroz, R; Alam, KM; Blok, DC; Bresser, P; de Jong, MD; Dondorp, AM; Ghose, A; Hassan, M; Hossain, A; Kager, LM; Lede, IO; Lutter, R; Meijers, JC; Rahman, W; Tanck, MW; van der Poll, T; van der Zee, JS; Veer, CV; Visser, CE; Zahed, AS | 1 |
| Shchukin, SP | 1 |
| Ding, D; Guo, SW; Liu, X; Wu, Q | 1 |
| Carrozas, MA; Montilla, M; Ruiz, FA; Santi, MJ | 1 |
| Davidson, SJ; Davies, NA; Evans, PA; Evans, VJ; Harrison, NK; Hawkins, K; Lawrence, MJ; Morris, RH; Noble, S; Sabra, A; Williams, PR | 1 |
| Chatelain, B; Chatelain, C; Dogné, JM; Douxfils, J; Mullier, F | 1 |
| Caldwell, CC; England, LG; Friend, LA; Goodman, MD; Kuethe, JW; Midura, EF; Rice, TC; Veile, R | 1 |
| Bergh, E; Forman, EJ; Franasiak, JM; Lonczak, A; Patounakis, G; Scott, RT; Tao, X; Treff, N | 1 |
| Anglés-Cano, E; Boada, C; Bueno, SR; Carrerra, C; Delgado, P; Fernández-Cadenas, I; Monasterio, J; Montaner, J; Penalba, A; Quiroga, A | 1 |
| Erdem, HB; Eroz, R; Ozdemir, G; Ozel, L; Sahin, I; Tasdemir, S; Tatar, A | 1 |
| Ikeda, T; Ikejiri, M; Kamimoto, Y; Nakatani, K; Wada, H | 1 |
| Meus, R; Sobczyk, D; Son, M; Undas, A | 1 |
| Albright, RC; Bridges, AD; Claus, PL; Davis, MD; Dillon, JJ; El-Azhary, RA; El-Zoghby, ZM; Hickson, LJ; Kumar, R; McBane, RD; McCarthy, JT; McCarthy-Fruin, KA; McEvoy, MT; Patzelt, MT; Pittelkow, MR; Weaver, AL; Wetter, DA; Williams, AW | 1 |
| Couturaud, F; Galinat, H; Lacut, K; Mingant, F; Roche, C; Thereaux, J | 1 |
| Alessandrini, F; Brandimarti, F; Catalani, C; De Angelis, L; Galeazzi, R; Gesuita, R; Giorgetti, R; Giovagnetti, S; Pesaresi, M; Righi, E; Tagliabracci, A | 1 |
| Akay, OM; Anıl, H; Aydoğdu, S; Bör, Ö; Bozkurt Turhan, A; Harmancı, K; Kılıç Yıldırım, G; Kocak, A | 1 |
| Leng, RX; Liang, Y; Pan, HF; Ye, DQ | 1 |
| Cushman, M; Fried, LF; Katz, R; Keller, C; Shlipak, M | 1 |
| Favaloro, EJ; Franchini, M; Guidi, GC; Lippi, G; Montagnana, M; Salvagno, GL; Targher, G | 1 |
| Chen, F; Luo, XP; Ning, Q; Pi, B; Su, K; Xi, D; Xu, L; Yan, WM; Zeng, QL | 1 |
| Akay, OM; Canturk, Z; Gulbas, Z; Mutlu, FS; Ustuner, Z | 1 |
| Andreotti, F; Becker, RC; Chan, MY | 1 |
| Ehlert, U; Redwine, LS; von Känel, R; Wirtz, PH | 1 |
| Akar, N; Deda, G; Ertem, M; Teber, S; Unal, O | 1 |
| Atalla, R; Saha, P; Stott, D | 1 |
| Jax, TW; Peters, AJ; Plehn, G; Schoebel, FC | 1 |
| Berny, MA; Conley, RB; Eshel-Green, T; McCarty, OJ | 1 |
| Cetin, A; Cetin, M; Kocak, N; Ozdemir, O; Ozen, F; Yenicesu, C; Yenicesu, GI; Yildiz, C | 1 |
| Ayala, R; Bustelos, R; Garfia, C; Grande, S; Martin, MA; Martinez, J; Meneu, JC; Moreno, A; Moreno, E; Perez, B; Ribera, C; Toledo, T | 1 |
| de Vicente Sánchez, J; Gredilla Díaz, E; Laporta Báez, Y; Pérez Ferrer, A | 1 |
| Antonov, A; Ivanov, P; Kovacheva, K; Vulkova, A | 1 |
| Criado, PR; Di Giacomo, TB; Hussein, TP; Souza, DG | 1 |
| Amato, A; Cini, M; Conti, E; Favaretto, E; Legnani, C; Palareti, G; Sartori, M | 1 |
| Iversen, PO; Sioud, M; Sørensen, DR | 1 |
| Liu, YF; Wei, Q; Yang, L; Yang, P; Zeng, H | 1 |
| Akyol, A; Kadikoylu, G; Kiylioglu, N; Ozkul, A; Tataroglu, C; Turgut, ET; Yenisey, C | 1 |
| Fu, R; Qiu, J; Wu, P; Wu, S | 1 |
| Borowiecka, M; Nowak, P; Polac, I; Ponczek, MB; Radwan, P; Wachowicz, B | 1 |
| Bedi, VS; Mishra, MN | 1 |
| Fritsch, M; Fritsch, P; Kleber, M; Laschnik, B; Mangge, H; Muntean, W; Reinehr, T; Schlagenhauf, A | 1 |
| Bălşeanu, AT; Dănoiu, S; Iancu, I; Mitran, SI; Moţa, M; Pisoschi, C; Riza, A; Sfredel, V | 1 |
| Couto, G; Lara García, A; Vilar Saavedra, P; Zaldívar López, S | 1 |
| Calcaterra, V; de Silvestri, A; Gamba, G; Lanati, G; Larizza, D; Montani, N; Terulla, V | 1 |
| Brooks, MM; Frye, RL; Genuth, S; Hardison, RM; Huber, K; Krishnaswami, A; McBane, RD; Pratley, RE; Schneider, DJ; Sobel, BE; Wolk, R | 1 |
| Butenas, S; Gissel, M; Mann, KG; Slowik, A; Undas, A | 1 |
| Arkebauer, MR; Nielsen, VG; Vosseller, K | 1 |
| Conti, E; Favaretto, E; Frascaro, M; Legnani, C; Palareti, G; Sartori, M | 1 |
| Brenner, B; Klein, E; Makhoul, B; Robicsek, O; Sarig, G | 1 |
| Ayala, R; Bustelos, R; Cedena, T; Jimenez, C; Martínez-López, J; Moreno, E; Ribera, C | 1 |
| Preuss, C; Stoll, M | 1 |
| Gong, J; Li, S; Wei, S; Wu, C; Zhu, R | 1 |
| Burov, IeIu; Dronov, OI; Fedoruk, PV; Fedoruk, VI; Koval's'ka, IO; Roshchyna, LO | 1 |
| Campbell, RA; Di Paola, J; Lin, FC; Ma, AD; Mackman, N; Marchi, R; McGary, CS; Pawlinski, R; Walton, BL; Wolberg, AS | 1 |
| Dulak, J; Guzik, TJ | 1 |
| Batta, Z; Benyo, M; Flasko, T; Harsfalvi, J; Jozsa, T; Kerenyi, A; Molnar, Z | 1 |
| Burghardt, S; Giers, G; Handschel, J; Kübler, NR; Naujoks, C | 1 |
| Berlit, P; Harbrecht, U; Klockgether, T; Kraus, JA; Müller, J; Nahser, HC; Stüper, BK | 1 |
| de Bosch, NB; Echenagucia, M; Mosesson, MW; Rodriguez-Lemoin, A; Ruiz-Sáez, A | 1 |
| Blann, AD; Chin, BS; Kamath, S; Lip, GY | 1 |
| De Staercke, C; Hooper, WC | 1 |
| Browett, PJ; Cooke, G; French, JK; Gao, W; Goldschmidt-Clermont, P; Liu-Stratton, Y; Lund, M; McDowell, J; Pohorence, J; Sutton, TM; Szymanski, D; Van de Water, NS; White, HD | 1 |
| Barthels, M; Eisert, R; Franke, K; Haberbosch, W; Meyer, M; Richter, W; Schenk, J; Seyfert, UT; Steiniger, F; Treuner, J | 1 |
| Bernardi, F; Coccheri, S; Ferraresi, P; Gemmati, D; Legnani, C; Lunghi, B; Marchetti, G; Palareti, G; Pinotti, M; Scapoli, C | 1 |
| Bavbek, N; Dagli, M; Kosar, A; Ozturk, M; Sengul, N | 1 |
| Arya, R; Asonganyi, B; Ford, E; Jackson, SH; Mangoni, AA; Ouldred, E; Sherwood, RA; Swift, CG | 1 |
| FIELD, JB; LARSEN, EG | 1 |
| Watzke, HH | 1 |
| BARRUCAND, L; TINOCO, EM | 1 |
| ARTURSON, G; WALLENIUS, G | 1 |
| Dimsdale, JE; von Känel, R | 1 |
| Baumann, M; Heemann, U; Kribben, A; Niebel, W; Philipp, T | 1 |
| Antensteiner, G; Grimm, C; Hefler, L; Heim, K; Husslein, P; Jirecek, S; Tempfer, C; Zeillinger, R | 1 |
| Khandoga, A; Kreyling, W; Krombach, F; Radykewicz, R; Schulz, H; Stampfl, A; Takenaka, S | 1 |
| D'Agostino, RB; Levy, D; Lipinska, I; Massaro, J; Mittleman, MA; Muller, JE; Rosito, GA; Sutherland, P; Tofler, GH; Wilson, PW | 1 |
| Akimoto, H; Baba, S; Fukuchi, M; Kagaya, Y; Kumagai, K; Oda, K; Ohta, J; Shirato, K; Tabayashi, K; Watanabe, J | 1 |
| Camilleri, RS; Cohen, H; Everington, T; Peebles, D; Portmann, C | 1 |
| Fijnheer, R; Probst, K; Rothova, A | 1 |
| Alessi, MC; Juhan-Vague, I; Morange, PE | 1 |
| Ford, I; Lowe, GD; McMahon, AD; O'Reilly, DS; Packard, CJ; Rumley, A | 1 |
| Kiesewetter, H; Koscielny, J; Latza, R; Pruss, A; Radtke, H; Salama, A; Schmutzler, M; Sinha, P; Ziemer, S | 1 |
| Ghosh, K; Khare, A; Kulkarni, B; Mohanty, D; Shetty, S | 1 |
| Brummel-Ziedins, KE; Mann, KG; Undas, A | 1 |
| Hiura, H | 1 |
| Allman-Farinelli, MA; Dawson, B | 1 |
| Brenner, B; Dally, N; Haddad, N; Hoffman, R; Rowe, JM; Sarig, G | 1 |
| Broom, I; McNeill, G; Mutch, WJ; Tuya, C | 1 |
| Kanayama, N; Kobayashi, T; Matsuura, T; Murakami, Y; Ohashi, R; Omatsu, K; Sugimura, M; Suzuki, M | 1 |
| Cichocki, L; El-Shabrawi, Y; Haas, A; Lechner, H; Renner, W; Schmut, O; Stanger, O; Steinbrugger, I; Temmel, W; Weger, M | 1 |
| García, A; Lip, GY; Marín, F; Roldán, V; Tello-Montoliu, A | 1 |
| Akdemir, O; Demir, M; Ekuklu, G; Ozbay, G; Turgut, B; Turgut, N; Utku, U; Vural, O | 1 |
| Breteler, MM; Conway, DS; Heeringa, J; Hofman, A; Lip, GY; van der Kuip, DA; Witteman, JC | 1 |
| de Mazancourt, P; de Raucourt, E; Fischer, AM; Meyer, G | 1 |
| Dörner, T; Hoppe, B; Kiesewetter, H; Salama, A; Tolou, F | 1 |
| Gonano, C; Kettner, SC; Meitner, E; Sitzwohl, C; Weinstabl, C | 1 |
| Gomibuchi, H; Iwai, S; Kobayashi, S; Kumai, T; Oguchi, K; Okazaki, M | 1 |
| Hayashi, M; Juen, H; Sagesaka, T | 1 |
| Ay, C; Dorda, W; Pabinger, I; Simanek, R; Tengler, T; Vormittag, R; Vukovich, T | 1 |
| Buseri, FI; Jeremiah, ZA; Shokunbi, WA | 1 |
| Papadimitriou, DK; Pitoulias, GA; Tachtsi, MD; Tsiaousis, PZ | 1 |
| Berliner, S; Karni, Y; Maharshak, N; Raz, O; Rogowski, O; Shapira, I | 1 |
| Madoiwa, S; Mimuro, J; Miyata, M; Niwa, K; Ohmori, T; Sakata, Y; Sugo, T; Tei, C | 1 |
| Day, JR; Ghimire, G; Leong, HS; Mahesh, BM; McCormack, AD; Podor, TJ; Rose, ML; Smith, JD | 1 |
| Krania, E; Kremastinos, DT; Liakos, GK; Panagiotakos, DB; Rallidis, LS; Vikelis, M | 1 |
| Bärtschi, C; Ehlert, U; Spillmann, M; von Känel, R; Wirtz, PH | 1 |
| Brenner, B; Jacob, G; Masoud, M; Sarig, G | 1 |
| Acosta, A; Baptista, T; Carrizo, E; Connell, L; Fernández, V; Mosquera, M; Quintero, J; Rodríguez, Z | 1 |
| Baertschi, C; Ehlert, U; Redwine, LS; Spillmann, M; von Känel, R; Wirtz, PH | 1 |
| Fujise, M; Hamasaki, N; Hattori, S; Iida, H; Kinoshita, S; Nakahara, M; Tanabe, S; Tsuda, H | 1 |
| Asanuma, H; Funaya, H; Hori, M; Kitakaze, M; Koretsune, Y; Minamino, T; Sato, H | 1 |
| Jäger, K; Labs, KH; Marbet, GA; Tsakiris, DA; Tschopl, M | 1 |
| Fukui, M; Hamasaki, N; Hattori, S; Ikezaki, K; Kinoshita, S; Matsushima, T; Nishioka, S; Tanabe, S; Tsuda, H | 1 |
| Watanabe, K | 1 |
| d'Alessio, D; De Lucia, D; Del Giudice, V; Di Mauro, C; Iacoviello, L; Maisto, G; Marotta, R; Pezzella, S | 1 |
| Côté, HC; Lord, ST; Pratt, KP | 1 |
| Adány, R; Bárdos, H; Juhász, A; Répássy, G | 1 |
| Montes, R; Panizo, C; Páramo, JA; Rocha, E | 1 |
| Aznar, J; Ferrando, F; Martínez, M; Mira, Y; Santaolaria, ML; Vayá, A; Villa, P | 1 |
| Blann, AD; Goldsmith, I; Li-Saw-Hee, FL; Lip, GY | 1 |
| Carter, AM; Catto, AJ; Grant, PJ | 1 |
| Ambrose, JA; Badimon, JJ; Cohen, AM; Dangas, G; Fallon, JT; Levine, D; Meraj, P; Shao, JH; Smith, DA; Unger, AH | 1 |
| Dempfle, CE | 1 |
| Ridker, PM | 1 |
| Kapsoritakis, A; Kouroumalis, EA; Koutroubakis, IE; Maladaki, A; Manousos, ON; Mouzas, IA; Roussomoustakaki, M; Sfiridaki, A | 1 |
| Grant, PJ; Lane, DA | 1 |
| Backhouse, O; Lee, D; Mahomed, I; Parapia, L | 1 |
| Barlage, S; Lackner, KJ; Schmitz, G; von Landenberg, C | 1 |
| Din, G; Hu, J; Liu, Z; Wei, W; Yuan, L | 1 |
| Heilmann, L; Hommel, G; Nieman, F; von Tempelhoff, GF | 1 |
| Katz, M; Mankuta, D; Meiselman, HJ; Meyerstein, D; Meyerstein, N; Pribush, A; Silberstein, T | 1 |
| Bouma, BN; Büller, HR; Meijers, JC; Middeldorp, S; Prins, MH; Rosing, J; Tans, G; van den Ende, AE; van Enk, A | 1 |
| Miodońska, J; Uszyński, M; Ziółkowska, E | 1 |
| Gürakan, F; Koçak, N; Ozen, H; Saltik, IN; Yüce, A | 1 |
| Brooks, MB; Otto, CM; Rieser, TM; Russell, MW | 1 |
| Aissa-Benhaddad, A; Baskürt, O; Bouchahda, C; Brun, JF; Granat, MC; Mercier, J; Sagnes, C | 1 |
| Fujita, S; Fukamizu, M; Kaizu, K; Nakajima, S; Noguchi, T; Tabuchi, M; Taka, T; Ueda, T; Yamamoto, J | 1 |
| Falsey, AR; Francis, CW; Hall, WJ; Horan, JT; Kolassa, J; Smith, BH | 1 |
| Aisaka, K; Kaibara, M; Liang, SG; Okinaga, S; Ooka, F; Watanabe, T | 1 |
| Buchholz, T; Hasbargen, U; Hiller, E; Lohse, P; Pihusch, R; Rogenhofer, N; Rübsamen, H; Thaler, CJ | 1 |
| Mannucci, PM; Tripodi, A | 1 |
| Feldman, EC; Gosselin, R; Jacoby, RC; Ortega, T; Owings, JT | 1 |
| Aznar, J; Martinez, M; Martínez-Sales, V; Palencia, MA; Réganon, E; Vayá, A; Vila, V | 1 |
| Golec, DB | 1 |
| Kisiel, W; Kozlowski, L; Kudryk, BJ; Piotrowski, Z; Rucinska, M; Wojtukiewicz, MZ; Zacharski, LR; Zimnoch, L | 1 |
| Coccheri, S; Legnani, C; Lunghi, B; Palareti, G; Preda, L; Rossi, E | 1 |
| Arber, N; Avitzour, D; Berliner, S; Elishkewich, K; Fusman, R; Izkhacov, E; Rotstein, R; Rubinstein, A; Shapira, I; Zeltser, D | 1 |
| Brandt, JT; Cunningham, MT; Laposata, M; Olson, JD | 1 |
| Swedenborg, J; Thor, M; Yu, A | 1 |
30 review(s) available for fibrinogen and Hypercoagulability
| Article | Year |
|---|---|
Markers of Hereditary Thrombophilia with Unclear Significance.
Topics: Endothelial Protein C Receptor; Factor IX; Fibrinogen; Humans; Plasminogen Activator Inhibitor 1; Thrombophilia; Thrombosis | 2022 |
Pathophysiological Response to Trauma-Induced Coagulopathy: A Comprehensive Review.
Topics: Animals; Blood Coagulation; Blood Platelets; Endothelium, Vascular; Fibrinogen; Fibrinolysis; Humans; Phenotype; Platelet Activation; Prognosis; Risk Factors; Thrombin; Thrombophilia; Wounds and Injuries | 2020 |
Coronavirus Disease 2019 Coagulopathy: Disseminated Intravascular Coagulation and Thrombotic Microangiopathy-Either, Neither, or Both.
Topics: Animals; Betacoronavirus; Coronavirus Infections; COVID-19; Disease Models, Animal; Disseminated Intravascular Coagulation; Ferritins; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Mice; Pandemics; Pneumonia, Viral; Prothrombin Time; SARS-CoV-2; Thrombocytopenia; Thrombophilia; Thrombotic Microangiopathies | 2020 |
Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow's triad.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Betacoronavirus; Blood Platelets; Blood Viscosity; Coronavirus Infections; COVID-19; Endothelium, Vascular; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolytic Agents; Heparin; Humans; Pandemics; Peptidyl-Dipeptidase A; Plasminogen Activator Inhibitor 1; Platelet Activation; Platelet Aggregation Inhibitors; Pneumonia, Viral; SARS-CoV-2; Severity of Illness Index; Thrombophilia; Thrombosis; Tissue Plasminogen Activator | 2020 |
COVID-19 Associated Hypercoagulability: Manifestations, Mechanisms, and Management.
Topics: Anticoagulants; Blood Coagulation Tests; Blood Viscosity; Combined Modality Therapy; Correlation of Data; COVID-19; Endothelium, Vascular; Extracorporeal Membrane Oxygenation; Factor VIII; Fibrinogen; Fibrinolysis; Humans; Monitoring, Physiologic; Respiration, Artificial; Thrombelastography; Thrombophilia | 2021 |
Revisiting One of the Dreaded Outcomes of the Current Pandemic: Pulmonary Embolism in COVID-19.
Topics: Anticoagulants; Computed Tomography Angiography; COVID-19; Disease Management; Disseminated Intravascular Coagulation; Echocardiography; Extracorporeal Membrane Oxygenation; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Lower Extremity; Partial Thromboplastin Time; Platelet Count; Point-of-Care Systems; Prothrombin Time; Pulmonary Embolism; Thrombolytic Therapy; Thrombophilia; Ultrasonography, Doppler, Duplex; Venous Thrombosis; Ventilation-Perfusion Scan | 2020 |
COVID-19-related laboratory coagulation findings.
Topics: Antibodies, Antiphospholipid; Biomarkers; Blood Coagulation Factors; Blood Coagulation Tests; COVID-19; Disseminated Intravascular Coagulation; Factor Xa; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Heparin, Low-Molecular-Weight; Humans; Partial Thromboplastin Time; Platelet Count; Prothrombin Time; SARS-CoV-2; Thrombelastography; Thrombin; Thrombophilia | 2021 |
AGA Clinical Practice Update: Coagulation in Cirrhosis.
Topics: Anticoagulants; Antifibrinolytic Agents; Antithrombins; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Transfusion; Factor Xa Inhibitors; Fibrinogen; Hematocrit; Heparin; Humans; International Normalized Ratio; Liver Cirrhosis; Plasma; Platelet Count; Portal Vein; Thrombelastography; Thrombocytopenia; Thrombophilia; Thrombopoietin; Transfusion Reaction; Venous Thrombosis | 2019 |
The relationship between pancreatic cancer and hypercoagulability: a comprehensive review on epidemiological and biological issues.
Topics: Animals; Anticoagulants; Antithrombin III; Cell-Derived Microparticles; Disease Models, Animal; Extracellular Traps; Factor VIII; Factor Xa Inhibitors; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Glucuronidase; Heparin; Humans; Leukocytes; Membrane Glycoproteins; Mice; Molecular Targeted Therapy; Pancreatic Neoplasms; Protein C; Thrombophilia; Thromboplastin; Thrombosis | 2019 |
Colorectal cancer and hypercoagulability.
Topics: Anticoagulants; Blood Coagulation Factors; Blood Platelets; Colorectal Neoplasms; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Molecular Targeted Therapy; Platelet Aggregation Inhibitors; Prognosis; Thrombophilia | 2014 |
The simultaneous occurrence of both hypercoagulability and hypofibrinolysis in blood and serum during systemic inflammation, and the roles of iron and fibrin(ogen).
Topics: Animals; Blood Coagulation; Computer Simulation; Fibrin; Fibrinogen; Fibrinolysis; Humans; Inflammation; Iron; Models, Immunological; Thrombophilia | 2015 |
Hypercoagulable states in cardiovascular disease.
Topics: Blood Coagulation Factors; Cardiovascular Diseases; Disease Susceptibility; Fibrinogen; Fibrinolysis; Humans; Polymorphism, Single Nucleotide; Prothrombin; Risk Factors; Thromboembolism; Thrombophilia; Thromboplastin; Thrombosis | 2008 |
Inherited risk factors for thrombotic diseases in children: the genome-wide perspective.
Topics: Adult; Anticoagulants; Child; Drug Resistance; Factor V; Family; Fibrinogen; Genome-Wide Association Study; Humans; Infant, Newborn; Methylenetetrahydrofolate Reductase (NADPH2); Phenotype; Risk Factors; Stroke; Thrombophilia; Venous Thrombosis | 2011 |
Venous thromboembolism: implications for gene-based diagnosis and technology development.
Topics: Activated Protein C Resistance; Blood Proteins; Disease Susceptibility; Epistasis, Genetic; Factor V; Female; Fibrinogen; Forecasting; Genetic Predisposition to Disease; Humans; Hyperhomocysteinemia; Male; Molecular Diagnostic Techniques; Neoplasms; Platelet Membrane Glycoproteins; Pregnancy; Pregnancy Complications, Hematologic; Prothrombin; Thromboembolism; Thrombophilia; Venous Thrombosis | 2002 |
Clinical significance of gene-diagnosis for defects in coagulation factors and inhibitors.
Topics: Adolescent; Adult; Anticoagulants; Blood Coagulation Factors; Child; DNA, Complementary; Exons; Factor IX; Factor V; Factor VIII; Factor XIII; Female; Fibrinogen; Genetic Linkage; Genetic Predisposition to Disease; Genetic Techniques; Hemophilia A; Hemophilia B; Hemorrhage; Homozygote; Humans; Introns; Logistic Models; Male; Mutation; Odds Ratio; Point Mutation; Polymorphism, Genetic; Pregnancy; Prenatal Diagnosis; Pulmonary Embolism; Risk Factors; Thrombophilia; Thrombosis; Venous Thrombosis | 2003 |
Hemostatic alterations in patients with obstructive sleep apnea and the implications for cardiovascular disease.
Topics: Blood Platelets; Cardiovascular Diseases; Continuous Positive Airway Pressure; Fibrinogen; Hemostasis; Humans; Risk Factors; Sleep Apnea, Obstructive; Thrombophilia | 2003 |
Relations between hemostatic variables, insulin resistance and inflammation.
Topics: Adipose Tissue; Adult; Aged; C-Reactive Protein; Cohort Studies; Cytokines; Female; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Inflammation; Insulin Resistance; Male; Metabolic Syndrome; Middle Aged; Obesity; Plasminogen Activator Inhibitor 1; Thrombophilia; von Willebrand Factor | 2004 |
Statins and blood coagulation.
Topics: Animals; Anticholesteremic Agents; Anticoagulants; Arteriosclerosis; Blood Coagulation; Blood Coagulation Factors; Blood Proteins; Factor VII; Fibrinogen; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Models, Biological; Protein Prenylation; Protein Processing, Post-Translational; Staphylococcal Protein A; Thrombin; Thrombomodulin; Thrombophilia; Thromboplastin; Venous Thrombosis | 2005 |
[Fibrinogen (factor I) and dys (functional) -fibrinogen].
Topics: Afibrinogenemia; Biomarkers; Blood Coagulation Disorders; Blood Coagulation Tests; Disseminated Intravascular Coagulation; Fibrinogen; Hemorrhagic Disorders; Humans; Liver Diseases; Neoplasms; Reference Values; Severity of Illness Index; Thrombophilia | 2004 |
Diet and aging: bearing on thrombosis and hemostasis.
Topics: Aging; Alcohols; Bleeding Time; Carbohydrate Metabolism; Diet; Dietary Fats; Factor VII; Fatty Acids; Fatty Acids, Unsaturated; Fibrinogen; Hemostasis; Humans; Isoflavones; Niacin; Nutritional Physiological Phenomena; Plasminogen Activator Inhibitor 1; Platelet Aggregation; Risk; Thrombophilia; Thrombosis; Thromboxane A2; Tissue Plasminogen Activator | 2005 |
[Etiological analysis of thrombophilia].
Topics: Antithrombin III; Clinical Laboratory Techniques; Fibrinogen; Heparin Cofactor II; Humans; Lupus Coagulation Inhibitor; Mutation; Plasminogen; Protein C; Protein S; Thrombophilia | 1997 |
[Clinical diagnosis of thrombosis and blood coagulation tests].
Topics: Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Antithrombin III; Biomarkers; Blood Coagulation Tests; Disseminated Intravascular Coagulation; Fibrinogen; Humans; Lupus Coagulation Inhibitor; Protein C; Protein S; Reference Standards; Thrombophilia | 1998 |
gamma-Chain dysfibrinogenemias: molecular structure-function relationships of naturally occurring mutations in the gamma chain of human fibrinogen.
Topics: Adult; Afibrinogenemia; Amino Acid Sequence; Binding Sites; Blood Coagulation; Crystallization; Female; Fibrinogen; Hemorrhagic Disorders; Humans; Infant; Male; Models, Molecular; Molecular Sequence Data; Mutation; Point Mutation; Protein Conformation; Structure-Activity Relationship; Thrombophilia | 1998 |
Acute generalized, widespread bleeding. Diagnosis and management.
Topics: Acute Disease; Algorithms; Antibodies, Monoclonal; Anticoagulants; Antifibrinolytic Agents; Blood Coagulation Factors; Blood Coagulation Tests; Contraindications; Cytokines; Diagnosis, Differential; Disseminated Intravascular Coagulation; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Hematologic Diseases; Hemorrhage; Heparin; Humans; Infections; Liver Diseases; Neoplasms; Plasma; Platelet Transfusion; Thrombophilia | 1998 |
The use of soluble fibrin in evaluating the acute and chronic hypercoagulable state.
Topics: Acute Disease; Animals; Blood Coagulation; Chronic Disease; Disseminated Intravascular Coagulation; Epitopes; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Plasminogen; Thrombophilia; Venous Thrombosis | 1999 |
Novel risk factors and markers for coronary disease.
Topics: Biomarkers; C-Reactive Protein; Coronary Disease; Fibrinogen; Fibrinolysis; Homocysteine; Humans; Hyperhomocysteinemia; Lipoprotein(a); Risk Factors; Thrombophilia; Vasculitis | 2000 |
Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease.
Topics: 3' Untranslated Regions; Arterial Occlusive Diseases; Blood Coagulation Factors; Factor V; Factor VII; Factor XIII; Fibrinogen; Fibrinolysis; Genetic Predisposition to Disease; Hemostasis; Humans; Hyperhomocysteinemia; Plasminogen Activator Inhibitor 1; Platelet Membrane Glycoproteins; Point Mutation; Polymorphism, Genetic; Prothrombin; Receptors, Cell Surface; Risk Factors; Sequence Deletion; Thromboembolism; Thrombophilia; Tissue Plasminogen Activator; Venous Thrombosis | 2000 |
[Hemorheological aspects of leuko-platelet activation in atheromatous diseases: clinical applications].
Topics: Arterial Occlusive Diseases; Arteriosclerosis; Biomarkers; Blood Platelets; Blood Viscosity; Cytokines; Endothelium, Vascular; Feedback; Fibrinogen; Free Radicals; Hemorheology; Humans; Inflammation; Ischemia; Leg; Leukocytes; Nitric Oxide; Risk Factors; Thrombophilia; Thrombosis | 2000 |
Laboratory investigation of thrombophilia.
Topics: Activated Protein C Resistance; Antiphospholipid Syndrome; Antithrombins; Clinical Laboratory Techniques; Coronary Thrombosis; Factor V; Factor VIII; Fibrinogen; Humans; Hyperhomocysteinemia; Mutation; Protein C; Protein S; Prothrombin; Stroke; Thrombophilia; Venous Thrombosis | 2001 |
Laboratory diagnosis of dysfibrinogenemia.
Topics: Algorithms; Blood Coagulation Disorders, Inherited; Fibrinogen; Humans; Mutation; Thrombin Time; Thrombophilia | 2002 |
12 trial(s) available for fibrinogen and Hypercoagulability
| Article | Year |
|---|---|
Rosuvastatin use increases plasma fibrinolytic potential: a randomised clinical trial.
Topics: Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Biomarkers; Carboxypeptidase B2; Female; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Rosuvastatin Calcium; Thrombophilia | 2020 |
TEG Lysis Shutdown Represents Coagulopathy in Bleeding Trauma Patients: Analysis of the PROPPR Cohort.
Topics: Adult; alpha-2-Antiplasmin; Female; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Retrospective Studies; Thrombelastography; Thrombophilia | 2019 |
Impact on hemostatic parameters of interrupting sitting with intermittent activity.
Topics: Aged; Biomarkers; Blood Coagulation Tests; Blood Volume; Cross-Over Studies; Erythrocyte Count; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hematocrit; Hemoglobins; Humans; Leukocyte Count; Male; Middle Aged; Obesity; Overweight; Platelet Count; Sedentary Behavior; Thrombophilia; Walking | 2013 |
Hypercoagulability in cancer patients grouped by syndromes differentiated with the theory of abnormal hilit in traditional Uyghur medicine.
Topics: Adult; Blood Coagulation; Diagnosis, Differential; Female; Fibrinogen; Humans; Male; Medicine, Chinese Traditional; Neoplasms; Platelet Count; Prothrombin Time; Thrombophilia; Young Adult | 2014 |
Normalization of haemostatic alterations in overweight children with weight loss due to lifestyle intervention.
Topics: Adolescent; Behavior Therapy; Blood Coagulation Tests; Body Mass Index; Chi-Square Distribution; Child; Diet, Reducing; Exercise Therapy; Female; Fibrinogen; Germany; Hemostasis; Humans; Male; Overweight; Prospective Studies; Risk Reduction Behavior; Thrombin; Thrombophilia; Time Factors; Treatment Outcome; Weight Loss | 2011 |
Profibrinolytic, antithrombotic, and antiinflammatory effects of an insulin-sensitizing strategy in patients in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
Topics: Adult; Biomarkers; C-Reactive Protein; Coronary Disease; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Follow-Up Studies; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Inflammation; Insulin; Insulin Resistance; Kaplan-Meier Estimate; Male; Metformin; Middle Aged; Myocardial Revascularization; Plasminogen Activator Inhibitor 1; Prognosis; Sulfonylurea Compounds; Thiazolidinediones; Thrombophilia; Tissue Plasminogen Activator | 2011 |
Potential thrombophilic mutations/polymorphisms in patients with no flow-limiting stenosis after myocardial infarction.
Topics: Adult; Coronary Stenosis; Factor V; Female; Fibrinogen; Gene Frequency; Humans; Male; Middle Aged; Mutation; Myocardial Infarction; Polymorphism, Genetic; Risk Factors; Thrombophilia | 2003 |
Effects of folic acid supplementation on inflammatory and thrombogenic markers in chronic smokers. A randomised controlled trial.
Topics: Adult; Biomarkers; Blood Proteins; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Folic Acid; Homocysteine; Humans; Inflammation; International Normalized Ratio; Male; Middle Aged; Partial Thromboplastin Time; Smoking; Thrombophilia; Treatment Outcome | 2003 |
Interleukin-6, fibrin D-dimer, and coagulation factors VII and XIIa in prediction of coronary heart disease.
Topics: Angioplasty, Balloon, Coronary; Biomarkers; Case-Control Studies; Coronary Disease; Factor VII; Factor XIIa; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertension; Incidence; Inflammation; Interleukin-6; Male; Middle Aged; Monocytes; Myocardial Infarction; Myocardial Revascularization; Pravastatin; Predictive Value of Tests; Risk Factors; Scotland; Thrombophilia; Triglycerides | 2004 |
Four-day antithrombin therapy does not seem to attenuate hypercoagulability in patients suffering from sepsis.
Topics: Adult; Aged; Antithrombins; Double-Blind Method; Drug Administration Schedule; Female; Fibrinogen; Humans; Male; Middle Aged; Platelet Count; Sepsis; Thrombophilia | 2006 |
Effect of oral melatonin on the procoagulant response to acute psychosocial stress in healthy men: a randomized placebo-controlled study.
Topics: Acute Coronary Syndrome; Administration, Oral; Adult; Antigens; Catecholamines; Central Nervous System Depressants; Factor VII; Factor VIII; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Melatonin; Stress, Psychological; Thrombophilia | 2008 |
Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study.
Topics: Adolescent; Adult; Antithrombin III; Biomarkers; Blood Coagulation; Blood Coagulation Factors; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cross-Over Studies; Desogestrel; Ethinyl Estradiol; Female; Fibrinogen; Humans; Levonorgestrel; Peptide Fragments; Peptide Hydrolases; Prothrombin; Risk Factors; Thrombin; Thrombophilia; Venous Thrombosis | 2000 |
178 other study(ies) available for fibrinogen and Hypercoagulability
| Article | Year |
|---|---|
Association of coagulation disturbances with severity of COVID-19: a longitudinal study.
Topics: Adult; Aged; Blood Coagulation; COVID-19; Disseminated Intravascular Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Longitudinal Studies; Male; Middle Aged; Partial Thromboplastin Time; Severity of Illness Index; Thrombophilia | 2021 |
Inflammatory Markers and Mortality in Diabetic Versus Idiopathic Gastroparesis.
Topics: Biomarkers; C-Reactive Protein; Diabetes Mellitus; Factor VIII; Fibrinogen; Gastroparesis; Humans; Inflammation; Retrospective Studies; Thrombophilia | 2022 |
Hypercoagulability in patients with indirect carotid cavernous fistulas.
Topics: Antibodies, Anticardiolipin; Antithrombin III; Atrial Fibrillation; Female; Fibrinogen; Fistula; Homocysteine; Humans; Lupus Coagulation Inhibitor; Male; Protein C; Prothrombin; Thrombophilia | 2022 |
Hypercoagulation detected by routine and global laboratory hemostasis assays in patients with infective endocarditis.
Topics: Adult; Aged; Blood Platelets; Endocarditis; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostasis; Humans; Male; Middle Aged; Partial Thromboplastin Time; Platelet Activation; Polymorphism, Single Nucleotide; Prothrombin; Thrombelastography; Thrombophilia | 2021 |
Assessment of Coagulation Profiles by Rotational Thromboelastometry in COVID 19 Patients.
Topics: Adult; Blood Coagulation Disorders; Blood Coagulation Tests; COVID-19; Fibrinogen; Humans; SARS-CoV-2; Thrombelastography; Thrombophilia | 2022 |
[Peculiarities of blood coagulation disorders in patients with COVID-19].
Topics: Anticoagulants; Blood Coagulation Disorders; C-Reactive Protein; COVID-19; Disseminated Intravascular Coagulation; Ethanol; Fibrinogen; Hemostatics; Heparin, Low-Molecular-Weight; Humans; Inflammation; Interleukins; SARS-CoV-2; Thrombophilia; Thrombosis | 2021 |
The Correlation between the Triglyceride-Glucose Index and Coagulation Markers in Patients with Recent Acute Myocardial Infarction.
Topics: Aged; Biomarkers; Blood Glucose; Coronary Artery Disease; Female; Fibrinogen; Glucose; Hemostatics; Humans; Male; Metabolic Syndrome; Middle Aged; Myocardial Infarction; Risk Assessment; Risk Factors; Thrombophilia; Triglycerides | 2022 |
Hyperfibrinolysis drives mechanical instabilities in a simulated model of trauma induced coagulopathy.
Topics: Blood Coagulation Disorders; Fibrin; Fibrinogen; Hemodilution; Hemostatics; Humans; Thrombophilia; Thromboplastin; Tissue Plasminogen Activator; Tranexamic Acid | 2022 |
Time Course of Coagulopathy Evaluated with Rotational Thromboelastometry in Patients with Severe Coronavirus Disease 2019.
Topics: Adult; Blood Coagulation Disorders; Blood Coagulation Tests; COVID-19; Fibrinogen; Humans; Retrospective Studies; Thrombelastography; Thrombophilia | 2023 |
An interaction between the inflammatory condition and the hypercoagulable condition occurs in primary Sjögren syndrome.
Topics: Biomarkers; Blood Sedimentation; C-Reactive Protein; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Inflammation; Sjogren's Syndrome; Thrombophilia | 2023 |
Estradiol provokes hypercoagulability and affects fibrin biology: A mechanistic exploration of sex dimorphisms in coagulation.
Topics: Blood Coagulation Disorders; Estradiol; Female; Fibrin; Fibrinogen; Humans; Male; Prospective Studies; Proteomics; Sex Characteristics; Thrombelastography; Thrombin; Thrombophilia; Thrombosis | 2023 |
RISK OF PLACENTA-ASSOCIATED COMPLICATIONS AT PREECLAMPSIA IN PREGNANT WOMEN WITH THROMBOPHILIA.
Topics: Angiotensinogen; Factor V; Female; Fibrinogen; Humans; Placenta; Plasminogen Activator Inhibitor 1; Pre-Eclampsia; Pregnancy; Pregnant Women; Prospective Studies; Prothrombin; Thrombophilia | 2022 |
Coagulation profiles in patients with sepsis/septic shock identify mixed hypo-hypercoagulation patterns based on rotational thromboelastometry: A prospective observational study.
Topics: Adolescent; Adult; Blood Coagulation Disorders; Blood Coagulation Tests; Fibrinogen; Humans; Prospective Studies; Sepsis; Shock, Septic; Thrombelastography; Thrombophilia | 2023 |
Uncovering hypercoagulation status using rotational thromboelastometry in patients with sepsis presented with hypocoagulation based on conventional coagulation tests: an observational study.
Topics: Blood Coagulation; Female; Fibrinogen; Humans; Male; Sepsis; Thrombelastography; Thrombophilia | 2023 |
GRSF1 antagonizes age-associated hypercoagulability via modulation of fibrinogen mRNA stability.
Topics: Aged; Animals; Fibrinogen; Gene Expression Regulation; Humans; Mice; Poly(A)-Binding Proteins; RNA, Messenger; Thrombophilia | 2023 |
Circulating tumour cells and hypercoagulability: a lethal relationship in metastatic breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antithrombin III; Biomarkers, Tumor; Breast Neoplasms; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Middle Aged; Neoplasm Metastasis; Neoplastic Cells, Circulating; Peptide Hydrolases; Prognosis; Survival Rate; Thrombophilia | 2020 |
Hypercoagulation and Hypermetabolism of Fibrinogen in Severely Burned Adults.
Topics: Adolescent; Adult; Blood Coagulation Tests; Blood Glucose; Burns; Case-Control Studies; Female; Fibrinogen; Heart Rate; Humans; Lactic Acid; Length of Stay; Male; Respiratory Rate; Serum Albumin; Thrombophilia; Young Adult | 2020 |
Transferrin plays a central role in coagulation balance by interacting with clotting factors.
Topics: Adult; Aged; Aged, 80 and over; Animals; Antithrombins; Apolipoproteins E; Atherosclerosis; Blood Coagulation; Blood Coagulation Factors; Down-Regulation; Factor XIIa; Female; Fibrinogen; Humans; Iron; Mice, Inbred C57BL; Middle Aged; Thrombin; Thrombophilia; Transferrin | 2020 |
COVID-19-Related Severe Hypercoagulability in Patients Admitted to Intensive Care Unit for Acute Respiratory Failure.
Topics: Acute Disease; Aged; Area Under Curve; Betacoronavirus; Blood Coagulation; Blood Coagulation Tests; Coronavirus Infections; COVID-19; Critical Care; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Intensive Care Units; Italy; Male; Middle Aged; Pandemics; Pneumonia, Viral; Prognosis; Respiration Disorders; SARS-CoV-2; Thrombelastography; Thrombophilia; Treatment Outcome | 2020 |
Prognostic value of plasma fibrinogen and D-dimer levels in patients with surgically resected non-small cell lung cancer.
Topics: Aged; Biomarkers, Tumor; Blood Coagulation Disorders; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Lung Neoplasms; Male; Pneumonectomy; Preoperative Period; Prognosis; Survival Rate; Thrombophilia; Venous Thromboembolism | 2020 |
Analysis of thrombophilic gene mutations in coronary artery ectasia.
Topics: Aged; Atherosclerosis; Case-Control Studies; Coronary Vessels; Dilatation, Pathologic; Factor V; Factor XIII; Female; Fibrinogen; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Plasminogen Inactivators; Polymorphism, Genetic; Prothrombin; Retrospective Studies; Thrombophilia | 2020 |
Factor VIII and Functional Protein C Activity in Critically Ill Patients With Coronavirus Disease 2019: A Case Series.
Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Antithrombins; Betacoronavirus; C-Reactive Protein; Comorbidity; Coronavirus Infections; COVID-19; Critical Illness; Diabetes Mellitus; Dyslipidemias; Extracorporeal Membrane Oxygenation; Factor VIII; Female; Ferritins; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Hypertension; International Normalized Ratio; Male; Middle Aged; Obesity; Pandemics; Partial Thromboplastin Time; Pneumonia, Viral; Protein C; Prothrombin Time; Renal Dialysis; Renal Insufficiency, Chronic; Respiration, Artificial; Respiratory Distress Syndrome; SARS-CoV-2; Thrombophilia | 2020 |
The protective rather than prothrombotic fibrinogen in COVID-19 and other inflammatory states.
Topics: Acute Disease; Acute-Phase Proteins; Betacoronavirus; Biomarkers; Blood Platelets; Coronavirus Infections; COVID-19; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Inflammation; Models, Cardiovascular; Pandemics; Pneumonia, Viral; Risk; SARS-CoV-2; Thrombophilia; Thrombosis; von Willebrand Factor | 2020 |
Circulating Plasminogen Concentration at Admission in Patients with Coronavirus Disease 2019 (COVID-19).
Topics: Adult; Aged; Betacoronavirus; Blood Cell Count; Comorbidity; Coronavirus Infections; COVID-19; Disease Progression; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Fibrinolysis; Humans; Male; Middle Aged; Pandemics; Patient Admission; Plasminogen; Pneumonia, Viral; Respiratory Distress Syndrome; SARS-CoV-2; Thrombophilia | 2020 |
Evaluation of COVID-19 coagulopathy; laboratory characterization using thrombin generation and nonconventional haemostasis assays.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Blood Coagulation Tests; COVID-19; Critical Illness; Cross-Sectional Studies; Enzyme-Linked Immunosorbent Assay; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Lipoproteins; Male; Middle Aged; Pandemics; Platelet Count; Retrospective Studies; SARS-CoV-2; Thrombin; Thrombophilia; Tissue Plasminogen Activator; Vascular Endothelial Growth Factor A; Young Adult | 2021 |
Protein C and Protein S Levels in β-Thalassemia Major Patients in Erbil, Kurdistan Region.
Topics: Adult; beta-Thalassemia; Case-Control Studies; Erythrocytes; Female; Fibrinogen; Hemoglobins; Humans; Male; Protein C; Protein S; Thrombophilia; Thrombosis; Young Adult | 2020 |
Presence of nucleosomes in plasma and increased thrombin generation in dogs with acute and chronic gastroenteropathies.
Topics: Animals; Chronic Disease; Dog Diseases; Dogs; Enzyme-Linked Immunosorbent Assay; Female; Fibrinogen; Gastroenteritis; Lymphoma; Male; Nucleosomes; Prospective Studies; Thrombin; Thrombophilia | 2021 |
Marked von Willebrand factor and factor VIII elevations in severe acute respiratory syndrome coronavirus-2-positive, but not severe acute respiratory syndrome coronavirus-2-negative, pneumonia: a case-control study.
Topics: ADAMTS13 Protein; Aged; Biomarkers; Blood Cell Count; C-Reactive Protein; Case-Control Studies; COVID-19; Factor VIII; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Pneumonia; SARS-CoV-2; Thrombophilia; von Willebrand Factor | 2021 |
Rotational thromboelastometry (ROTEM) profiling of COVID-19 patients.
Topics: Adult; Aged; Aged, 80 and over; Blood Coagulation; Blood Coagulation Tests; Comorbidity; COVID-19; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Interleukin-6; Male; Middle Aged; Prognosis; Severity of Illness Index; Thrombelastography; Thromboembolism; Thrombophilia; Young Adult | 2021 |
Association of D-dimer and Fibrinogen With Hypercoagulability in COVID-19 Requiring Extracorporeal Membrane Oxygenation.
Topics: Adult; C-Reactive Protein; COVID-19; Extracorporeal Membrane Oxygenation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Retrospective Studies; Sensitivity and Specificity; Thrombelastography; Thrombophilia | 2021 |
Von Willebrand factor and ADAMTS13 activity as clinical severity markers in patients with COVID-19.
Topics: ADAMTS13 Protein; Aged; Ambulatory Care; Biomarkers; Correlation of Data; COVID-19; Endothelium, Vascular; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Intensive Care Units; Male; Middle Aged; Prospective Studies; Risk Assessment; SARS-CoV-2; Severity of Illness Index; Spain; Thrombophilia; von Willebrand Factor | 2021 |
Evaluation of coagulation status using clot waveform analysis in general ward patients with COVID-19.
Topics: C-Reactive Protein; COVID-19; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Retrospective Studies; Thrombophilia; Thrombosis | 2022 |
Thrombogenicity markers for early diagnosis and prognosis in COVID-19: a change from the current paradigm?
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Black or African American; Cardiovascular Diseases; Comorbidity; COVID-19; COVID-19 Testing; Diabetes Mellitus; Early Diagnosis; Female; Fibrin; Fibrin Clot Lysis Time; Fibrinogen; Hospitalization; Humans; Hyperlipidemias; L-Lactate Dehydrogenase; Male; Middle Aged; Obesity; Organ Dysfunction Scores; Prognosis; Prospective Studies; SARS-CoV-2; Thrombelastography; Thrombophilia; Treatment Outcome; White People | 2021 |
Biomarkers of Coagulation and Inflammation in COVID-19-Associated Ischemic Stroke.
Topics: Aged; Aged, 80 and over; Blood Sedimentation; C-Reactive Protein; Cluster Analysis; COVID-19; Female; Ferritins; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hospital Mortality; Humans; Inflammation; Interleukin-6; Ischemic Stroke; L-Lactate Dehydrogenase; Leukocyte Count; Logistic Models; Machine Learning; Male; Middle Aged; Myocardial Infarction; Partial Thromboplastin Time; Pulmonary Embolism; Retrospective Studies; SARS-CoV-2; Severity of Illness Index; Thrombophilia; Venous Thrombosis | 2021 |
Monitoring of Hypercoagulability by Thromboelastography in Bariatric Surgery.
Topics: Adult; Bariatric Surgery; Biomarkers; Blood Coagulation; Female; Fibrinogen; Humans; Male; Middle Aged; Obesity; Postoperative Period; Predictive Value of Tests; ROC Curve; Thrombelastography; Thrombophilia; Venous Thrombosis | 2017 |
Comparison of platelet function and viscoelastic test results between healthy dogs and dogs with naturally occurring chronic kidney disease.
Topics: Animals; Blood Platelets; Dog Diseases; Dogs; Fibrinogen; Flow Cytometry; P-Selectin; Partial Thromboplastin Time; Platelet Activation; Platelet Function Tests; Platelet Glycoprotein GPIb-IX Complex; Platelet Glycoprotein GPIIb-IIIa Complex; Prothrombin Time; Renal Insufficiency, Chronic; Thrombelastography; Thrombophilia | 2017 |
Genetic markers for inherited thrombophilia are associated with fetal growth retardation in the population of Central Russia.
Topics: Adolescent; Adult; Case-Control Studies; Factor V; Factor VII; Female; Fetal Growth Retardation; Fibrinogen; Genetic Markers; Humans; Middle Aged; Pregnancy; Prothrombin; Russia; Thrombophilia; Young Adult | 2017 |
Discussion of: "The hypercoagulability paradox of chronic kidney disease: The role of fibrinogen".
Topics: Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostatics; Humans; Renal Insufficiency, Chronic; Thrombophilia | 2017 |
Coagulation Alteration and Deep Vein Thrombosis in Brain Tumor Patients During the Perioperative Period.
Topics: Adult; Aged; Biomarkers; Blood Coagulation; Brain Neoplasms; Craniotomy; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Perioperative Period; Postoperative Complications; Thrombophilia; Venous Thrombosis | 2018 |
Thromboelastography Values Remain Hypercoagulative 6 Months After Obesity Surgery: a Pilot Study.
Topics: Adult; Bariatric Surgery; Blood Coagulation; Blood Coagulation Tests; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Follow-Up Studies; Humans; Male; Middle Aged; Obesity, Morbid; Pilot Projects; Postoperative Complications; Thrombelastography; Thrombophilia; Time Factors | 2018 |
An iTRAQ-Based Quantitative Proteomic Analysis of Plasma Proteins in Preterm Newborns With Retinopathy of Prematurity.
Topics: Birth Weight; Blood Proteins; Complement C3; Female; Fibrinogen; Gene Expression Regulation; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Inflammation; Male; Proteomics; Retinopathy of Prematurity; Retrospective Studies; Thrombophilia | 2018 |
The hemostasis system in children with hereditary spherocytosis.
Topics: Adolescent; Child; Child, Preschool; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostasis; Humans; Infant; Male; Spherocytosis, Hereditary; Thrombelastography; Thrombophilia | 2019 |
C-reactive protein and fibrin clot strength measured by thrombelastography after coronary stenting.
Topics: Aged; Angioplasty, Balloon, Coronary; Blood Coagulation; C-Reactive Protein; Calcium Chloride; Coronary Artery Disease; Female; Fibrin; Fibrinogen; Humans; Inflammation; Kaolin; Male; Middle Aged; Risk Factors; Stents; Thrombelastography; Thrombophilia; Thrombosis | 2013 |
Primary antiphospholipid antibody syndrome-one further aspect of thrombophilia in overweight and obese patients with venous thromboembolism.
Topics: Adult; Aged; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Body Mass Index; Body Weight; Female; Fibrinogen; Humans; Inflammation; Male; Middle Aged; Obesity; Overweight; Retrospective Studies; Risk Factors; Thrombophilia; Venous Thromboembolism | 2013 |
The association between thrombophilic gene mutations and recurrent pregnancy loss.
Topics: Abortion, Habitual; Adult; Factor V; Factor VII; Factor VIII; Female; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Integrin alpha2; Mutation; Peptidyl-Dipeptidase A; Plasminogen Activator Inhibitor 1; Pregnancy; Prothrombin; Risk Factors; Thrombophilia; Young Adult | 2013 |
[The inherited procoagulant and prothrombotic condition as the main etiological factor for ischemic stroke in infants].
Topics: Brain Ischemia; Child, Preschool; Female; Fibrinogen; Fibrinolysis; Humans; Infant; Integrin alpha2; Male; Methylenetetrahydrofolate Reductase (NADPH2); Polymorphism, Single Nucleotide; Stroke; Thrombophilia | 2013 |
A novel natural mutation AαPhe98Ile in the fibrinogen coiled-coil affects fibrinogen function.
Topics: Abortion, Spontaneous; Adult; Batroxobin; Blood Coagulation; Blood Coagulation Tests; Female; Fibrin; Fibrinogen; Fibrinolysis; Heterozygote; Humans; Platelet Aggregation; Point Mutation; Pregnancy; Protein Conformation; Thrombin; Thrombophilia; Time Factors | 2014 |
Patients with antineutrophil cytoplasmic antibodies associated vasculitis in remission are hypercoagulable.
Topics: Adult; Aged; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Antineutrophil Cytoplasmic; Factor VIII; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Follow-Up Studies; Humans; Lipoproteins; Male; Middle Aged; Protein C; Protein S; Remission Induction; Risk Factors; Thrombin; Thrombophilia; Venous Thromboembolism | 2013 |
High plasma estradiol interacts with diabetes on risk of dementia in older postmenopausal women.
Topics: Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; Case-Control Studies; Cohort Studies; Dementia; Diabetes Mellitus; Estradiol; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; France; Humans; Inflammation; Multivariate Analysis; Postmenopause; Proportional Hazards Models; Risk; Risk Factors; Testosterone; Thrombin; Thrombophilia | 2014 |
Thromboelastometry as a supplementary tool for evaluation of hemostasis in severe sepsis and septic shock.
Topics: Aged; Aged, 80 and over; Anticoagulants; Blood Cell Count; Blood Coagulation Tests; Blood Component Transfusion; Critical Care; Disseminated Intravascular Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemorrhage; Hemorrhagic Disorders; Hemostasis; Humans; Male; Middle Aged; Prospective Studies; Sepsis; Severity of Illness Index; Shock, Septic; Thrombelastography; Thrombin; Thrombophilia | 2014 |
In vitro hypercoagulability on whole blood thromboelastometry associated with in vivo reduction of circulating red cell mass in dogs.
Topics: Anemia; Animals; Blood Coagulation; Citric Acid; Dog Diseases; Dogs; Erythrocyte Volume; Female; Fibrinogen; Male; Platelet Count; Thrombelastography; Thrombin; Thrombophilia | 2014 |
Coexistence of hypofibrinogenemia and factor V Leiden mutation: is the balance shifted to thrombosis?
Topics: Adult; Afibrinogenemia; Factor V; Fibrinogen; Heterozygote; Humans; Male; Point Mutation; Thrombophilia; Venous Thrombosis | 2014 |
Suboptimal glycaemic control enhances the risk of impaired prothrombotic state in youths with type 1 diabetes mellitus.
Topics: Adolescent; Child; Cross-Sectional Studies; Diabetes Mellitus, Type 1; Female; Fibrinogen; Glycated Hemoglobin; Humans; Male; Plasminogen Activator Inhibitor 1; Thrombophilia; von Willebrand Factor | 2014 |
Thrombophilia in patients with retinal vein occlusion: a retrospective analysis.
Topics: Aged; Antibodies, Anticardiolipin; Biomarkers; Female; Fibrinogen; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Prevalence; Retinal Vein Occlusion; Retrospective Studies; Risk Factors; Thrombophilia | 2014 |
Haemostatic factors, lipoproteins and long-term mortality in a multi-ethnic population of Gujarati, African-Caribbean and European origin.
Topics: Adult; Aged; Anthropometry; Antigens; Apolipoprotein A-I; Apolipoproteins B; Black People; Cardiovascular Diseases; Caribbean Region; Ethnicity; Europe; Factor VII; Female; Fibrinogen; Follow-Up Studies; Humans; India; Kaplan-Meier Estimate; London; Male; Middle Aged; Mortality; Proportional Hazards Models; Prospective Studies; Risk Factors; Sampling Studies; Thrombophilia; Vascular Stiffness; von Willebrand Factor; White People | 2014 |
Prevalence of thrombophilic genetic factors among patients with retinitis pigmentosa.
Topics: Adult; DNA Mutational Analysis; Factor V; Factor XIIIa; Female; Fibrinogen; Genetic Predisposition to Disease; Genotype; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Mutation; Plasminogen Activator Inhibitor 1; Prevalence; Receptors, Tumor Necrosis Factor, Type II; Retinitis Pigmentosa; Risk Factors; Thrombophilia; Young Adult | 2014 |
Study of the frequency of occurrence of genetic and acquired thrombophilia in infertile women prior IVF.
Topics: Adult; Factor V; Female; Fertilization in Vitro; Fibrinogen; Humans; Infant, Newborn; Infertility, Female; Integrin alpha2; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Plasminogen Activator Inhibitor 1; Polymorphism, Single Nucleotide; Pregnancy; Thrombophilia | 2014 |
[Analysis of the factors associated with abnormal coagulation and prognosis
in patients with non-small cell lung cancer].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Blood Coagulation; Blood Coagulation Tests; Carcinoma, Non-Small-Cell Lung; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; International Normalized Ratio; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Partial Thromboplastin Time; Platelet Count; Prognosis; Prothrombin Time; Risk Factors; Survival Analysis; Thrombophilia; Young Adult | 2014 |
Pulmonary tuberculosis induces a systemic hypercoagulable state.
Topics: Antithrombin III; Bangladesh; Biomarkers; Blood Coagulation; Bronchoalveolar Lavage Fluid; Bronchoscopy; Female; Fibrinogen; Humans; Inflammation; Male; Middle Aged; Peptide Hydrolases; Prospective Studies; Thrombophilia; Tuberculosis, Pulmonary | 2015 |
[Modern methods of diagnosis of thrombophylic states and complex treatment of patients with thrombotic complications of severe forms of varicose disease].
Topics: Anticoagulants; Factor V; Factor VII; Factor XII; Female; Fibrinogen; Gene Expression; Genetic Predisposition to Disease; Humans; Integrin alpha2; Integrin beta3; Leg; Male; Middle Aged; Mutation; Plasminogen Activator Inhibitor 1; Prothrombin; Thrombophilia; Varicose Veins; Venous Thrombosis | 2014 |
Evidence for a Hypercoagulable State in Women With Ovarian Endometriomas.
Topics: Adult; Biomarkers; Blood Coagulation; Case-Control Studies; Endometriosis; Female; Fibrinogen; Humans; Laparoscopy; Middle Aged; Partial Thromboplastin Time; Platelet Activation; Platelet Count; Predictive Value of Tests; Prothrombin Time; Thrombin Time; Thrombophilia; Treatment Outcome; Young Adult | 2015 |
Biomarkers of the prothrombotic state in abdominal obesity.
Topics: Adult; Anthropometry; Biomarkers; Blood Glucose; Cross-Sectional Studies; Fibrinogen; Follow-Up Studies; Humans; Lipids; Male; Mean Platelet Volume; Middle Aged; Obesity, Abdominal; Partial Thromboplastin Time; Platelet Count; Prothrombin; Thrombophilia | 2014 |
Application of ROTEM to assess hypercoagulability in patients with lung cancer.
Topics: Aged; Anticoagulants; Blood Coagulation; Blood Coagulation Tests; Case-Control Studies; Female; Fibrinogen; Hemostasis; Humans; Lung Neoplasms; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Risk Assessment; Thrombelastography; Thrombophilia; Treatment Outcome; Venous Thromboembolism | 2015 |
Edoxaban: Impact on routine and specific coagulation assays. A practical laboratory guide.
Topics: Antithrombins; Blood Coagulation; Blood Coagulation Tests; Blood Platelets; Calibration; Dose-Response Relationship, Drug; Factor Xa; Factor Xa Inhibitors; Fibrinogen; Hemostasis; Humans; Lupus Coagulation Inhibitor; Partial Thromboplastin Time; Plasma; Protein C; Protein S; Prothrombin Time; Pyridines; Sensitivity and Specificity; Thermogravimetry; Thiazoles; Thrombin; Thrombophilia | 2016 |
Impact of Platelets and Platelet-Derived Microparticles on Hypercoagulability Following Burn Injury.
Topics: Animals; Blood Coagulation; Blood Platelets; Burns; Cell-Derived Microparticles; Fibrinogen; Male; Mice; Platelet Count; Thrombelastography; Thrombophilia; von Willebrand Factor | 2016 |
Multiple thrombophilic single nucleotide polymorphisms lack a significant effect on outcomes in fresh IVF cycles: an analysis of 1717 patients.
Topics: Adult; Antigens, Human Platelet; Embryo Implantation; Factor V; Factor XIII; Female; Fertilization in Vitro; Fibrinogen; Genetic Predisposition to Disease; Humans; Infertility; Methylenetetrahydrofolate Reductase (NADPH2); Mutation; Plasminogen Activator Inhibitor 1; Polymorphism, Single Nucleotide; Pregnancy; Pregnancy Outcome; Prothrombin; Thrombophilia | 2016 |
Exome Sequencing and Clot Lysis Experiments Demonstrate the R458C Mutation of the Alpha Chain of Fibrinogen to be Associated with Impaired Fibrinolysis in a Family with Thrombophilia.
Topics: Blood Coagulation; Blood Coagulation Tests; Exome; Family Health; Female; Fibrin; Fibrinogen; Humans; Male; Mutation; Pedigree; Sequence Analysis, DNA; Thrombin; Thrombophilia; Thrombosis; Venous Thromboembolism | 2016 |
Correlation with Platelet Parameters and Genetic Markers of Thrombophilia Panel (Factor II g.20210G>A, Factor V Leiden, MTHFR (C677T, A1298C), PAI-1, β-Fibrinogen, Factor XIIIA (V34L), Glycoprotein IIIa (L33P)) in Ischemic Strokes.
Topics: Blood Coagulation Factors; Blood Platelets; Brain Ischemia; Factor V; Factor XIIIa; Fibrinogen; Genetic Markers; Genetic Predisposition to Disease; Humans; Plasminogen Activator Inhibitor 1; Polymorphism, Genetic; Prothrombin; Retrospective Studies; Risk Factors; Stroke; Thrombophilia | 2016 |
Protection From Pregnancy Loss in Women With Hereditary Thrombophilia When Associated With Fibrinogen Polymorphism Thr331Ala.
Topics: Abortion, Habitual; Case-Control Studies; Female; Fibrinogen; Humans; Polymorphism, Genetic; Pregnancy; Pregnancy Complications, Hematologic; Thrombophilia | 2017 |
Prothrombotic State in Patients With a Left Atrial Appendage Thrombus of Unknown Origin and Cerebrovascular Events.
Topics: Adult; Anticoagulants; Atrial Appendage; Atrial Fibrillation; Blood Coagulation Factors; Brain Ischemia; Case-Control Studies; Comorbidity; Endothelium, Vascular; Female; Fibrinogen; Fibrinolysis; Follow-Up Studies; Foramen Ovale, Patent; Heart Diseases; Humans; Ischemic Attack, Transient; Male; Middle Aged; Migraine Disorders; Platelet Count; Smoking; Stroke Volume; Thrombin; Thrombophilia; Thrombosis | 2016 |
Calciphylaxis: A Disease of Pannicular Thrombosis.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Antiphospholipid Syndrome; Calciphylaxis; Factor V; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Mutation; Plasminogen; Thrombophilia; Warfarin | 2016 |
Reduction of coagulability state one year after bariatric surgery.
Topics: Adult; Bariatric Surgery; Blood Coagulation Tests; C-Reactive Protein; Female; Fibrinogen; Gastrectomy; Gastric Bypass; Humans; Laparoscopy; Male; Obesity, Morbid; Postoperative Care; Prospective Studies; Thrombin; Thrombophilia; Treatment Outcome; Weight Loss | 2017 |
Investigation on genetic thrombophilic factors in FFPE autopsy tissue from subjects who died from pulmonary embolism.
Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Factor V; Factor XIII; Female; Fibrinogen; Formaldehyde; Genetic Predisposition to Disease; Glucuronidase; Heterozygote; Humans; Lipoproteins; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Paraffin Embedding; Plasminogen Activator Inhibitor 1; Polymerase Chain Reaction; Polymorphism, Genetic; Prothrombin; Pulmonary Embolism; Thrombophilia; Venous Thromboembolism | 2017 |
Thromboelastogram as a Tool to Predict Hypercoagulability in Children With Cystic Fibrosis.
Topics: Adolescent; Blood Coagulation Tests; Case-Control Studies; Child; Child, Preschool; Cystic Fibrosis; Female; Fibrinogen; Humans; Male; Thrombelastography; Thrombophilia | 2018 |
Effects of Disease Activity and Inflammatory Response on Hypercoagulability in Patients with Systemic Lupus Erythematosus.
Topics: Adult; Blood Sedimentation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Immunosuppressive Agents; Inflammation; Lupus Erythematosus, Systemic; Male; Retrospective Studies; Thrombophilia | 2016 |
Association of kidney function with inflammatory and procoagulant markers in a diverse cohort: a cross-sectional analysis from the Multi-Ethnic Study of Atherosclerosis (MESA).
Topics: Adult; Aged; Biomarkers; C-Reactive Protein; Cohort Studies; Creatinine; Cross-Sectional Studies; Cystatin C; Cystatins; Ethnicity; Factor VIII; Female; Fibrinogen; Glomerular Filtration Rate; Humans; Inflammation; Intercellular Adhesion Molecule-1; Interleukin-6; Kidney; Kidney Diseases; Male; Middle Aged; Receptors, Tumor Necrosis Factor, Type I; Thrombophilia; United States | 2008 |
Hyperthyroidism is associated with shortened APTT and increased fibrinogen values in a general population of unselected outpatients.
Topics: Adult; Aged; Aged, 80 and over; Female; Fibrinogen; Humans; Hyperthyroidism; Male; Middle Aged; Outpatients; Partial Thromboplastin Time; Retrospective Studies; Thrombophilia | 2009 |
Fibrinogen-like protein 2/fibroleukin prothrombinase contributes to tumor hypercoagulability via IL-2 and IFN-gamma.
Topics: Adult; Aged; Animals; Carcinoma, Hepatocellular; Cell Line; Cell Line, Tumor; Disease Models, Animal; Endothelial Cells; Female; Fibrinogen; Humans; Interferon-gamma; Interleukin-2; Leukemia, Monocytic, Acute; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Middle Aged; RNA, Messenger; Thrombophilia; Thromboplastin | 2008 |
Laboratory investigation of hypercoagulability in cancer patients using rotation thrombelastography.
Topics: Analysis of Variance; Blood Coagulation Tests; Female; Fibrinogen; Humans; Male; Neoplasms; Platelet Count; ROC Curve; Statistics, Nonparametric; Thrombelastography; Thrombophilia | 2009 |
Independent association between lower level of social support and higher coagulation activity before and after acute psychosocial stress.
Topics: Adult; Aged; Area Under Curve; Blood Coagulation; Factor VIII; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Norepinephrine; Social Isolation; Social Support; Stress, Psychological; Thrombophilia; Young Adult | 2009 |
Thrombophilic risk factors in epileptic children treated with valproic Acid.
Topics: Adolescent; Anticonvulsants; Antithrombin III; Blood Coagulation Factors; Child; Child, Preschool; Epilepsy; Female; Fibrinogen; Homocysteine; Humans; Infant; Lipoprotein(a); Male; Protein C; Protein S; Prothrombin; Risk Factors; Thrombophilia; Valproic Acid | 2009 |
Haemostatic changes in the puerperium '6 weeks postpartum' (HIP Study) - implication for maternal thromboembolism.
Topics: Blood Coagulation Factor Inhibitors; Cesarean Section; Female; Fibrinogen; Hemostasis; Humans; Partial Thromboplastin Time; Platelet Count; Postpartum Period; Pregnancy; Prospective Studies; Prothrombin Time; Puerperal Disorders; Thrombelastography; Thromboembolism; Thrombophilia; Time Factors | 2009 |
Hemostatic risk factors in patients with coronary artery disease and type 2 diabetes - a two year follow-up of 243 patients.
Topics: Acute Coronary Syndrome; Angina Pectoris; Blood Viscosity; Coronary Angiography; Coronary Artery Disease; Diabetes Mellitus, Type 2; Erythrocyte Aggregation; Fibrinogen; Fibrinolysis; Follow-Up Studies; Hemorheology; Humans; Hypercholesterolemia; Incidence; Myocardial Infarction; Myocardial Revascularization; Plasminogen Inactivators; Risk Factors; Thrombophilia | 2009 |
Effect of sex difference on platelet adhesion, spreading and aggregate formation under flow.
Topics: Animals; Blood Platelets; Cell Shape; Collagen; Confounding Factors, Epidemiologic; Crotalid Venoms; Female; Fibrinogen; Flow Cytometry; Humans; In Vitro Techniques; Lectins, C-Type; Male; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; P-Selectin; Platelet Adhesiveness; Platelet Aggregation; Rheology; Sex Characteristics; Siblings; Thrombin; Thrombophilia | 2009 |
A prospective case-control study analyzes 12 thrombophilic gene mutations in Turkish couples with recurrent pregnancy loss.
Topics: Abortion, Habitual; Adolescent; Adult; Apolipoproteins B; Apolipoproteins E; Case-Control Studies; Factor V; Female; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Heterozygote; Homozygote; Humans; Integrin beta3; Male; Methylenetetrahydrofolate Reductase (NADPH2); Mutation; Peptidyl-Dipeptidase A; Plasminogen Activator Inhibitor 1; Pregnancy; Pregnancy Complications, Hematologic; Prospective Studies; Prothrombin; Thrombophilia; Turkey; Young Adult | 2010 |
Living donor liver transplantation: usefulness of hemostatic and prothrombotic screening in potential donors.
Topics: Adult; Anticoagulants; Child, Preschool; Enoxaparin; Female; Fibrinogen; Hemostatics; Humans; Infant; Liver Transplantation; Living Donors; Male; Middle Aged; Partial Thromboplastin Time; Patient Selection; Platelet Count; Protein C; Prothrombin; Thromboembolism; Thrombophilia; Young Adult | 2009 |
[Reactive thrombocytosis: on the importance of hemostasis monitoring].
Topics: Adolescent; Anemia, Iron-Deficiency; Blood Coagulation Tests; Epidermolysis Bullosa; Fibrinogen; Hand; Humans; Male; Postoperative Complications; Preoperative Care; Skin Transplantation; Thrombelastography; Thrombocytosis; Thrombophilia | 2009 |
[Factor V Leiden and C677T MTHFR thrombophilic mutations associated with hyperfibrinogenemia, persistent high CRP and leucocytosis in newborn baby with perinatal infection--a clinical case].
Topics: Anti-Bacterial Agents; Factor V; Female; Fibrinogen; Humans; Infant, Newborn; Leukocytosis; Mutation; Pregnancy; Pregnancy Complications, Infectious; Receptors, Immunologic; Thrombophilia | 2009 |
Frequency of thrombophilia determinant factors in patients with livedoid vasculopathy and treatment with anticoagulant drugs--a prospective study.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Anticardiolipin; Anticoagulants; Blood Coagulation Tests; Factor V; Female; Fibrinogen; Heparin; Homocysteine; Humans; Lupus Coagulation Inhibitor; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Prospective Studies; Protein C; Protein S; Prothrombin; Skin Diseases, Vascular; Thrombophilia; Warfarin; Young Adult | 2010 |
Thrombophilic risk factors and peripheral arterial disease severity.
Topics: Aged; Constriction, Pathologic; Disease Progression; DNA Mutational Analysis; Factor VIII; Female; Fibrinogen; Homocysteine; Humans; Ischemia; Lupus Coagulation Inhibitor; Male; Mutation; Peripheral Arterial Disease; Polymorphism, Genetic; Prothrombin; Risk Factors; Thrombophilia | 2010 |
A combined immunostimulatory and immunoinhibitory short interference RNA reduces hypercoagulability in a rat model of acute promyelocytic leukaemia.
Topics: Animals; Antithrombin III; Biomarkers; Blood Coagulation; Cells, Cultured; Dendritic Cells; Disease Models, Animal; Fibrin Fibrinogen Degradation Products; Fibrinogen; Genetic Therapy; Interleukin-10; Leukemia, Promyelocytic, Acute; Male; Peptide Hydrolases; Plasminogen Activator Inhibitor 1; Rats; Rats, Inbred BN; RNA Interference; RNA, Small Interfering; Thrombophilia; Thromboplastin; Transfection | 2010 |
Mechanism and clinical significance of the prothrombotic state in patients with essential hypertension.
Topics: Aged; Biomarkers; Blood Coagulation; Blood Pressure; Case-Control Studies; Chi-Square Distribution; China; Endothelium, Vascular; Female; Fibrinogen; Humans; Hypertension; Male; Middle Aged; P-Selectin; Plasminogen Activator Inhibitor 1; Platelet Activation; Severity of Illness Index; Thrombophilia; Thrombosis; Vasodilation | 2010 |
The relationship between insulin resistance and hypercoagulability in acute ischemic stroke.
Topics: Aged; Female; Fibrinogen; Humans; Insulin Resistance; Male; Middle Aged; Neurologic Examination; Protein C; Protein S; Severity of Illness Index; Statistics as Topic; Stroke; Thrombophilia; von Willebrand Factor | 2010 |
A study of blood soluble P-selectin, fibrinogen, and von Willebrand factor levels in idiopathic and lone atrial fibrillation.
Topics: Adult; Anticoagulants; Atrial Fibrillation; Biomarkers; Case-Control Studies; Female; Fibrinogen; Humans; Male; Middle Aged; P-Selectin; Prognosis; Risk Factors; Thrombophilia; Thrombosis; von Willebrand Factor | 2011 |
Changes in hemostatic parameters after oral hormone therapy in postmenopausal women.
Topics: Case-Control Studies; Dydrogesterone; Estradiol; Estrogen Replacement Therapy; Female; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Longitudinal Studies; Middle Aged; Partial Thromboplastin Time; Platelet Count; Postmenopause; Prothrombin; Prothrombin Time; Risk Factors; Thrombophilia | 2010 |
Prevalence of common thrombophilia markers and risk factors in Indian patients with primary venous thrombosis.
Topics: Activated Protein C Resistance; Adult; Biomarkers; Epidemiologic Methods; Female; Fibrinogen; Humans; India; Male; Middle Aged; Popliteal Vein; Protein S; Risk Factors; Thrombophilia; Venous Thrombosis; Young Adult | 2010 |
Correlations between abdominal circumference and the breakage resistance of the fibrin clot in patients with diabetes mellitus type 2.
Topics: Aged; Brain Ischemia; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Hyperlipidemias; Male; Middle Aged; Myocardial Infarction; Obesity, Abdominal; Platelet Activation; Thrombophilia; Thrombosis; Time; Waist Circumference | 2010 |
Hemostatic abnormalities in dogs with carcinoma: a thromboelastographic characterization of hypercoagulability.
Topics: Animals; Antithrombin III; Case-Control Studies; Dog Diseases; Dogs; Female; Fibrinogen; Hemostasis; Hemostatic Disorders; Male; Neoplasms; Peptide Hydrolases; Plasminogen Activator Inhibitor 1; Thrombelastography; Thrombophilia | 2011 |
Thrombophilic screening in Turner syndrome.
Topics: Adolescent; Adult; Antithrombin III; Comorbidity; Factor VIII; Female; Fibrinogen; Genotype; Homocysteine; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Protein C; Protein S; Prothrombin; Thromboembolism; Thrombophilia; Turner Syndrome; Young Adult | 2011 |
Circulating activated factor XI and active tissue factor as predictors of worse prognosis in patients following ischemic cerebrovascular events.
Topics: Adult; Age Factors; Blood Coagulation Tests; Brain Ischemia; Factor XIa; Female; Fibrinogen; Humans; Interleukin-6; Ischemic Attack, Transient; Male; Middle Aged; Predictive Value of Tests; Prognosis; Stroke; Thrombophilia; Thromboplastin; Young Adult | 2011 |
Redox-based thrombelastographic method to detect carboxyhemefibrinogen-mediated hypercoagulability.
Topics: Blood Coagulation; Calcium; Carbon Monoxide; Dose-Response Relationship, Drug; Elastic Modulus; Fibrinogen; Heme; Humans; Hydroxylamines; Organometallic Compounds; Oxidation-Reduction; Plasma; Protein Binding; Smoking; Thrombelastography; Thrombophilia; Thromboplastin | 2011 |
Thrombotic risk factors and cardiovascular events after endovascular intervention for peripheral arterial disease.
Topics: Aged; Angioplasty; Cardiovascular Diseases; Factor V; Factor VIII; Female; Fibrinogen; Homocysteine; Humans; Intermittent Claudication; Ischemia; Leg; Lupus Coagulation Inhibitor; Male; Peripheral Arterial Disease; Proportional Hazards Models; Risk Factors; Stents; Thrombophilia; Thrombosis | 2011 |
Hypercoagulation in chronic post-traumatic stress disorder.
Topics: Activated Protein C Resistance; Adult; Biomarkers; Blood Coagulation Factors; Chronic Disease; Factor VIII; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Israel; Male; Peptide Fragments; Protein Precursors; Prothrombin; Stress Disorders, Post-Traumatic; Surveys and Questionnaires; Thrombophilia; Thromboplastin; von Willebrand Factor | 2011 |
Recipient and donor thrombophilia and the risk of portal venous thrombosis and hepatic artery thrombosis in liver recipients.
Topics: Adolescent; Adult; Antithrombins; Child; Child, Preschool; Factor VIII; Female; Fibrinogen; Graft Survival; Hepatic Artery; Humans; Infant; Kaplan-Meier Estimate; Liver Transplantation; Male; Middle Aged; Portal Vein; Proportional Hazards Models; Prospective Studies; Protein C; Retrospective Studies; Risk Factors; Thrombophilia; Thrombosis; Young Adult | 2011 |
Utility of clot formation and lysis assay to monitor global coagulation state of patients with severe acute pancreatitis.
Topics: Adult; Aged; Blood Coagulation Tests; Diagnosis, Computer-Assisted; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Monitoring, Physiologic; Pancreatitis; Plasminogen; Severity of Illness Index; Systemic Inflammatory Response Syndrome; Thrombophilia; Thrombosis | 2012 |
[The method of calculation of maximally admissable mass of adipose-cutaneous flap, excised during abdominoplasty].
Topics: Abdominal Wall; Adult; Aged; Body Mass Index; Female; Fibrinogen; Humans; Male; Middle Aged; Obesity; Plastic Surgery Procedures; Regression Analysis; Risk; Surgery, Plastic; Surgical Flaps; Thrombophilia | 2012 |
Dysregulated coagulation associated with hypofibrinogenaemia and plasma hypercoagulability: implications for identifying coagulopathic mechanisms in humans.
Topics: Afibrinogenemia; Amino Acid Substitution; Animals; Biopolymers; Blood Coagulation Tests; Carotid Artery Thrombosis; Disease Models, Animal; Electrophoresis, Gel, Two-Dimensional; Factor VIII; Female; Fibrinogen; Fibrinolysis; Gene Deletion; Hemorrhagic Disorders; Heterozygote; Humans; Ischemic Attack, Transient; Mice; Mice, Mutant Strains; Middle Aged; Mutation, Missense; Point Mutation; Retinal Artery Occlusion; Thrombin; Thrombophilia | 2012 |
Vessel wall--where coagulation meets cell biology and immunology.
Topics: Biomarkers; Blood Coagulation; C-Reactive Protein; Cerebrovascular Disorders; Chemokine CX3CL1; Coronary Disease; Endothelium, Vascular; Fibrinogen; Humans; Inflammation; Thrombophilia; Vasculitis | 2012 |
Follow-up of thrombin generation after prostate cancer surgery: global test for increased hypercoagulability.
Topics: Aged; Blood Cell Count; Body Mass Index; Fibrinogen; Follow-Up Studies; Hemostasis; Humans; Male; Middle Aged; Postoperative Period; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Statistics, Nonparametric; Thrombin; Thrombophilia | 2012 |
Parameters predicting complications in flap surgery.
Topics: Activated Protein C Resistance; Blood Coagulation Tests; C-Reactive Protein; Factor VIII; Female; Fibrinogen; Follow-Up Studies; Forecasting; Free Tissue Flaps; Hematologic Tests; Hemorrhagic Disorders; Humans; Male; Necrosis; Plastic Surgery Procedures; Platelet Function Tests; Postoperative Complications; Postoperative Hemorrhage; Prospective Studies; Reoperation; Skin Transplantation; Surgical Flaps; Thrombophilia; Thrombosis; Venous Thrombosis; von Willebrand Factor | 2013 |
Molecular analysis of thrombophilic risk factors in patients with dural arteriovenous fistulas.
Topics: Aged; Case-Control Studies; Central Nervous System Vascular Malformations; Cranial Sinuses; Factor V; Factor XIII; Female; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Oxidoreductases Acting on CH-NH Group Donors; Plasminogen Activator Inhibitor 1; Polymorphism, Genetic; Protein C; Prothrombin; Risk Factors; Thrombophilia | 2002 |
Inhibition of thrombin generation in plasma by fibrin formation (Antithrombin I).
Topics: Afibrinogenemia; Antithrombins; Fibrin; Fibrinogen; Hirudins; Humans; Peptide Fragments; Protein Binding; Prothrombin; Thrombin; Thrombophilia | 2002 |
A study of platelet activation in paroxysmal, persistent and permanent atrial fibrillation.
Topics: Aged; Atrial Fibrillation; beta-Thromboglobulin; Blood Viscosity; Case-Control Studies; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hematocrit; Hemorheology; Humans; Male; Middle Aged; Platelet Activation; Risk Factors; Thrombophilia | 2002 |
New molecular defects in the gamma subdomain of fibrinogen D-domain in four cases of (hypo)dysfibrinogenemia: fibrinogen variants Hannover VI, Homburg VII, Stuttgart and Suhl.
Topics: Adult; Albumins; Base Sequence; Blotting, Western; Calcium; DNA Mutational Analysis; Electrophoresis, Polyacrylamide Gel; Female; Fibrin; Fibrinogen; Fibrinolysin; Humans; Immunoblotting; Ligands; Male; Microscopy, Electron, Scanning; Middle Aged; Models, Molecular; Molecular Sequence Data; Mutation; Protein Binding; Protein Structure, Tertiary; Thrombophilia; Time Factors | 2003 |
Asymptomatic carriership of factor V Leiden and genotypes of the fibrinogen gene cluster.
Topics: Adolescent; Adult; Aged; DNA; Factor V; Female; Fibrinogen; Genotype; Heterozygote; Humans; Male; Middle Aged; Mutation; Polymorphism, Genetic; Thrombophilia; Venous Thrombosis | 2003 |
Global fibrinolytic capacity in colorectal cancer: a new clue to occult fibrinolysis.
Topics: Aprotinin; Colonic Neoplasms; Disseminated Intravascular Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Hemorrhagic Disorders; Humans; Male; Postoperative Complications; Postoperative Period; Prothrombin Time; Rectal Neoplasms; Risk; Thrombophilia; Tissue Plasminogen Activator; Venous Thrombosis | 2003 |
Hypercoagulability and liver dysfunction induced by compounds of some heavy metals.
Topics: Antimony; Arsenicals; Bismuth; Coagulants; Diuretics; Fibrinogen; Humans; Liver Diseases; Metals, Heavy; Organomercury Compounds; Prothrombin Time; Thrombophilia | 1954 |
[ADRENALINE AND HYPOFIBRINOGENEMIA. I. PARTICIPATION OF FIBRINOGEN B AND OF PROFIBRIN IN THE HYPERCOAGULABILITY OF HEMORRHAGIC SHOCK STATES].
Topics: Afibrinogenemia; Animals; Blood Coagulation Disorders; Blood Coagulation Tests; Dogs; Epinephrine; Fibrin; Fibrinogen; Pharmacology; Postoperative Complications; Reserpine; Shock; Shock, Hemorrhagic; Thrombophilia | 1963 |
HYPERCOAGULABILITY OF BLOOD AFTER BURN TRAUMA IN RATS. A PRELIMINARY REPORT.
Topics: Blood Coagulation Disorders; Blood Coagulation Tests; Burns; Factor IX; Factor VII; Factor VIII; Factor X; Fibrinogen; Heparin; Pharmacology; Prothrombin; Rats; Research; Shock, Traumatic; Thrombophilia | 1964 |
Primary failure of arteriovenous fistulae in auto-immune disease.
Topics: Adolescent; Adult; Aged; Autoimmune Diseases; Catheters, Indwelling; Child; Female; Fibrinogen; Humans; Male; Middle Aged; Renal Dialysis; Retrospective Studies; Risk Factors; Thrombophilia; Thrombosis; Vasculitis | 2003 |
Genetic polymorphisms associated with thrombophilia and vascular disease in women with unexplained late intrauterine fetal death: a multicenter study.
Topics: Adult; Apolipoproteins B; Apolipoproteins E; Case-Control Studies; Factor V; Factor XIII; Female; Fetal Death; Fibrinogen; Gestational Age; Hemochromatosis Protein; Histocompatibility Antigens Class I; Humans; Integrin beta3; Membrane Proteins; Methylenetetrahydrofolate Reductase (NADPH2); Polymorphism, Genetic; Pregnancy; Prothrombin; Thrombophilia; Vascular Diseases | 2004 |
Ultrafine particles exert prothrombotic but not inflammatory effects on the hepatic microcirculation in healthy mice in vivo.
Topics: Administration, Inhalation; Air Pollutants; Animals; Apoptosis; Biological Transport; Blood Platelets; Carbon; Endothelial Cells; Fibrinogen; Inflammation; Kupffer Cells; Leukocytes; Liver Circulation; Mice; Mice, Inbred C57BL; Microcirculation; Microscopy, Fluorescence; P-Selectin; Particle Size; Phagocytosis; Thrombophilia; Tissue Distribution; von Willebrand Factor | 2004 |
Association between obesity and a prothrombotic state: the Framingham Offspring Study.
Topics: Adult; Biomarkers; Body Mass Index; Factor VII; Family Health; Female; Fibrinogen; Hemostasis; Humans; Male; Middle Aged; Obesity; Plasminogen Activator Inhibitor 1; Risk Factors; Thrombophilia; Tissue Plasminogen Activator; Waist-Hip Ratio | 2004 |
Expression of the von Willebrand factor in atrial endocardium is increased in atrial fibrillation depending on the extent of structural remodeling.
Topics: Adult; Aged; Aged, 80 and over; Atrial Appendage; Atrial Fibrillation; Atrial Function; Endocardium; Female; Fibrin; Fibrinogen; Gene Expression; Heart Atria; Heart Valve Diseases; Humans; Male; Middle Aged; Mitral Valve; Platelet Endothelial Cell Adhesion Molecule-1; RNA, Messenger; Thrombophilia; von Willebrand Factor | 2004 |
-455G/A beta-fibrinogen gene polymorphism, factor V Leiden, prothrombin G20210A mutation and MTHFR C677T, and placental vascular complications.
Topics: 3' Untranslated Regions; Abruptio Placentae; Adolescent; Adult; Alleles; Amino Acid Substitution; DNA Mutational Analysis; Ethnicity; Factor V; Female; Fetal Death; Fetal Growth Retardation; Fibrinogen; Genetic Predisposition to Disease; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation, Missense; Placental Circulation; Point Mutation; Polymorphism, Genetic; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Complications, Hematologic; Prevalence; Prothrombin; Thrombophilia | 2004 |
Endothelial cell activation and hypercoagulability in ocular Behçet's disease.
Topics: Activated Protein C Resistance; Adult; Antigens; Antithrombin III; Behcet Syndrome; Cross-Sectional Studies; Endothelium, Vascular; Factor VIII; Female; Fibrinogen; Humans; Male; Middle Aged; Prospective Studies; Protein C; Protein S; Ristocetin; Thrombophilia; Venous Thrombosis; von Willebrand Factor | 2004 |
A practical concept for preoperative identification of patients with impaired primary hemostasis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antigens; Blood Coagulation; Blood Coagulation Disorders; Blood Coagulation Tests; Collagen; Elective Surgical Procedures; Epinephrine; Female; Fibrinogen; Humans; Male; Mass Screening; Medical Records; Middle Aged; Partial Thromboplastin Time; Platelet Activation; Platelet Function Tests; Predictive Value of Tests; Preoperative Care; Prevalence; Prospective Studies; ROC Curve; Sensitivity and Specificity; Surveys and Questionnaires; Thrombophilia; von Willebrand Factor | 2004 |
Combination of thrombophilia markers in acute myocardial infarction of the young.
Topics: Adult; Antithrombin III; Biomarkers; Coronary Angiography; Echocardiography; Electrophoresis, Polyacrylamide Gel; Factor V; Female; Fibrinogen; Homocysteine; Humans; Male; Myocardial Infarction; Point Mutation; Protein C; Risk Factors; Thrombophilia | 2004 |
Predictive factors of bleeding and thrombosis during induction therapy in acute promyelocytic leukemia-a single center experience in 34 patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Blood Coagulation Tests; Female; Fibrinogen; Hemorrhage; Humans; Leukemia, Promyelocytic, Acute; Leukocyte Count; Male; Middle Aged; Platelet Count; Predictive Value of Tests; Retrospective Studies; Risk Factors; Thrombophilia; Thrombosis | 2005 |
The effect of birth weight on clottable and intact fibrinogen levels: a twin study.
Topics: Adult; Birth Weight; Case-Control Studies; Databases, Factual; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Linear Models; Male; Middle Aged; Thrombophilia; Twins, Dizygotic; Twins, Monozygotic | 2005 |
Exogenous vascular endothelial growth factor can induce preeclampsia-like symptoms in pregnant mice.
Topics: Animals; Antibodies; Antithrombin III; Blood Pressure; Female; Fibrinogen; Mice; Peptide Hydrolases; Placenta; Pre-Eclampsia; Pregnancy; Thrombophilia; Vascular Endothelial Growth Factor A | 2005 |
Role of thrombophilic gene polymorphisms in branch retinal vein occlusion.
Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Factor V; Factor XII; Female; Fibrinogen; Genotype; Humans; Hypercholesterolemia; Hypertension; Integrin alpha2; Integrin beta3; Male; Middle Aged; Polymerase Chain Reaction; Polymorphism, Genetic; Prevalence; Prothrombin; Retinal Vein Occlusion; Retrospective Studies; Risk Factors; Thrombophilia | 2005 |
Is an advanced age an additive risk factor to the prothrombotic or hypercoagulable state in atrial fibrillation?
Topics: Aged, 80 and over; Atrial Fibrillation; Case-Control Studies; Cross-Sectional Studies; Female; Fibrinogen; Humans; Interleukin-6; Linear Models; Male; Multivariate Analysis; Prothrombin; Risk Factors; Thrombophilia; von Willebrand Factor | 2006 |
Hypercoagulopathy in stroke patients with nonvalvular atrial fibrillation: hematologic and cardiologic investigations.
Topics: Aged; Atrial Fibrillation; Case-Control Studies; Drug Evaluation; Female; Fibrinogen; Humans; Middle Aged; Peptide Fragments; Prothrombin; Severity of Illness Index; Stroke; Thrombophilia | 2006 |
A longitudinal population-based study of prothrombotic factors in elderly subjects with atrial fibrillation: the Rotterdam Study 1990-1999.
Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Blood Coagulation Factors; Case-Control Studies; Cohort Studies; Death; Female; Fibrinogen; Humans; Longitudinal Studies; Male; Netherlands; P-Selectin; Proportional Hazards Models; Risk Factors; Stroke; Thrombophilia; Thrombosis; von Willebrand Factor | 2006 |
A Bbeta 14 Arg --> Cys fibrinogen variant in a patient with thrombotic complications (fibrinogen St-Germain III).
Topics: Adult; Arginine; Cysteine; Fibrinogen; Heterozygote; Humans; Male; Mutation; Pedigree; Pulmonary Embolism; Risk Factors; Thrombophilia; Venous Thrombosis | 2006 |
Gene polymorphisms implicated in influencing susceptibility to venous and arterial thromboembolism: frequency distribution in a healthy German population.
Topics: Arterial Occlusive Diseases; Blood Coagulation Factors; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Germany; Humans; Integrin alpha2; Lipoproteins; Methylenetetrahydrofolate Reductase (NADPH2); Peptidyl-Dipeptidase A; Plasminogen Activator Inhibitor 1; Polymorphism, Single Nucleotide; Serine Endopeptidases; Thromboembolism; Thrombophilia; Tissue Plasminogen Activator; Venous Thrombosis | 2006 |
Development of hyperfibrinogenemia in spontaneously hypertensive and hyperlipidemic rats: a potentially useful animal model as a complication of hypertension and hyperlipidemia.
Topics: Animals; Antithrombin III; Blood Coagulation; Disease Models, Animal; Fibrinogen; Fibrinolysis; Hyperlipidemias; Hypertension; Male; Plasminogen; Prothrombin; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Sprague-Dawley; Thrombophilia | 2007 |
Influence of red blood cell concentration on the initiation time of blood coagulation: risk of thrombus formation in pregnant females with anemia.
Topics: Adult; Anemia; Blood Viscosity; Erythrocyte Count; Erythrocyte Deformability; Female; Fibrinogen; Hemorheology; Hemorrhage; Humans; Partial Thromboplastin Time; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Complications, Hematologic; Prothrombin Time; Risk Factors; Thrombophilia; Thrombosis | 2007 |
Venous thromboembolism--a manifestation of the metabolic syndrome.
Topics: Adult; Aged; Austria; Blood Glucose; Body Mass Index; C-Reactive Protein; Case-Control Studies; Cytokines; Factor VIII; Female; Fibrinogen; Humans; Male; Metabolic Syndrome; Middle Aged; Obesity; Odds Ratio; Prevalence; Prospective Studies; Pulmonary Embolism; Risk Factors; Thromboembolism; Thrombophilia; Triglycerides; Venous Thrombosis; Waist-Hip Ratio | 2007 |
Plasma levels of some blood coagulation parameters in Nigerian homozygous sickle cell patients (HbSS) in steady state.
Topics: Adolescent; Adult; Anemia, Sickle Cell; Blood Coagulation Factors; Blood Coagulation Tests; Case-Control Studies; Factor Xa; Female; Fibrinogen; Homozygote; Humans; Male; Nigeria; Thrombophilia | 2006 |
Hyperhomocysteinemia and hypercoagulable state in carotid plaque evolution. Novel risk factors or coincidental risk predictors?
Topics: Aged; Antithrombin III; Blood Coagulation Factors; Carotid Artery Diseases; Female; Fibrinogen; Follow-Up Studies; Greece; Homocysteine; Humans; Hyperhomocysteinemia; Immunoassay; Incidence; Male; Prognosis; Protein C; Protein S; Receptors, Cell Surface; Retrospective Studies; Risk Factors; Thrombophilia; Ultrasonography, Doppler, Duplex | 2007 |
Dissociated effects of physical activity and weight loss on fibrinogen concentrations and markers of red blood cell aggregation. Relevance for life style modification in atherothrombosis.
Topics: Adult; Biomarkers; Body Mass Index; Cholesterol; Cholesterol, LDL; Erythrocyte Aggregation; Female; Fibrinogen; Humans; Insulin; Life Style; Male; Middle Aged; Motor Activity; Obesity; Thrombophilia; Weight Loss | 2007 |
Dysfibrinogen Kagoshima with the amino acid substitution gammaThr-314 to Ile: analyses of molecular abnormalities and thrombophilic nature of this abnormal molecule.
Topics: Adult; Amino Acid Substitution; Calcium; Catalysis; Electrophoresis, Polyacrylamide Gel; Female; Fibrin; Fibrinogen; Fibrinogens, Abnormal; Fibrinolysin; Humans; Ions; Microscopy, Electron, Scanning; Polymerase Chain Reaction; Postpartum Period; Solubility; Surface Properties; Thrombin; Thrombophilia; Time Factors; Tissue Plasminogen Activator; Venous Thrombosis | 2008 |
Vimentin autoantibodies induce platelet activation and formation of platelet-leukocyte conjugates via platelet-activating factor.
Topics: Apoptosis; Autoantibodies; Autoimmune Diseases; Blood Platelets; Cell Adhesion; Complement C3d; Culture Media, Conditioned; Fibrinogen; Humans; Immunoglobulin M; Immunosorbent Techniques; Leukocytes; P-Selectin; Platelet Activating Factor; Platelet Activation; Pyridinium Compounds; Recombinant Proteins; Thrombophilia; Thromboplastin; Vimentin | 2008 |
Usefulness of inflammatory and haemostatic markers to predict short-term risk for death in middle-aged ischaemic stroke patients.
Topics: Biomarkers; Brain Ischemia; C-Reactive Protein; Encephalitis; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Predictive Value of Tests; Prognosis; Regression Analysis; Risk; Stroke; Thrombophilia; Tumor Necrosis Factor-alpha | 2008 |
Orthostatic hypercoagulability: a novel physiological mechanism to activate the coagulation system.
Topics: Adult; Blood Coagulation; Blood Pressure; Endothelium, Vascular; Factor V; Factor VIII; Female; Fibrinogen; Hematocrit; Humans; Male; Peptide Fragments; Plasma Volume; Posture; Protein C; Protein Precursors; Prothrombin; Thrombophilia; Thromboplastin; Venous Thromboembolism; von Willebrand Factor | 2008 |
Coagulation and inflammation markers during atypical or typical antipsychotic treatment in schizophrenia patients and drug-free first-degree relatives.
Topics: Adult; Antipsychotic Agents; Antithrombin III; Benzodiazepines; Body Mass Index; C-Reactive Protein; Clozapine; Dose-Response Relationship, Drug; Female; Fibrinogen; Humans; Inflammation Mediators; Leptin; Life Style; Male; Middle Aged; Olanzapine; Plasminogen Activator Inhibitor 1; Risk Factors; Schizophrenia; Thromboembolism; Thrombophilia | 2008 |
Coagulation activity before and after acute psychosocial stress increases with age.
Topics: Adult; Age Factors; Aged; Antigens; Arousal; Factor VII; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostasis; Humans; Male; Middle Aged; Psychophysiologic Disorders; Risk Factors; Stress, Psychological; Thrombophilia | 2008 |
Plasma levels of nitrite/nitrate and platelet cGMP levels are decreased in patients with atrial fibrillation.
Topics: Aged; Atrial Fibrillation; beta-Thromboglobulin; Blood Platelets; Blood Proteins; Cerebrovascular Disorders; Comorbidity; Cyclic GMP; Diabetes Mellitus; Echocardiography; Female; Fibrinogen; Hemodynamics; Humans; Hyperlipidemias; Hypertension; Male; Middle Aged; Myocardial Ischemia; Nitrates; Nitric Oxide; Nitrites; Risk Factors; Smoking; Thrombophilia | 1997 |
Role of hemostatic risk factors for restenosis in peripheral arterial occlusive disease after transluminal angioplasty.
Topics: Angioplasty, Balloon; Antithrombin III; Arterial Occlusive Diseases; Biomarkers; Blood Coagulation Tests; C-Reactive Protein; Cardiovascular Diseases; Comorbidity; Creatinine; Diabetes Mellitus; Female; Femoral Artery; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Hyperlipidemias; Lipids; Male; Metabolic Clearance Rate; Peptide Fragments; Peptide Hydrolases; Plasminogen Activator Inhibitor 1; Popliteal Artery; Prospective Studies; Prothrombin; Recurrence; Risk; Risk Factors; Smoking; Thrombin; Thrombophilia; Tissue Plasminogen Activator; Treatment Failure; Ultrasonography, Doppler, Color; von Willebrand Factor | 1997 |
Thrombophilia found in patients with moyamoya disease.
Topics: Adolescent; Adult; Aged; Anticoagulants; Antigens; Antithrombin III; Child; Child, Preschool; Fibrinogen; Humans; Moyamoya Disease; Plasminogen; Protein C; Protein S; Thrombophilia | 1997 |
A hypercoagulable state in activated protein C resistant patients with ischemic stroke.
Topics: Aged; Blood Coagulation Tests; Brain Ischemia; Enzyme Activation; Factor V; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Peptide Fragments; Protein C; Prothrombin; Thrombophilia | 1998 |
Fibrin deposition in squamous cell carcinomas of the larynx and hypopharynx.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Disease Progression; Female; Fibrin; Fibrinogen; Fluorescent Antibody Technique, Indirect; Humans; Hypopharyngeal Neoplasms; Keratins; Laryngeal Neoplasms; Macrophages; Male; Middle Aged; Neoplasm Proteins; Tenascin; Thrombophilia; Transglutaminases | 1998 |
Hemorheological alterations and hypercoagulable state in deep vein thrombosis.
Topics: Acenocoumarol; Acute Disease; Adult; Aged; Anticoagulants; Antithrombin III; Blood Coagulation; Blood Viscosity; Convalescence; Erythrocyte Aggregation; Female; Fibrinogen; Follow-Up Studies; Hemorheology; Heparin; Humans; Male; Middle Aged; Peptide Fragments; Peptide Hydrolases; Postoperative Complications; Prothrombin; Thrombophilia; Thrombophlebitis; Wounds and Injuries | 1998 |
Indexes of hypercoagulability measured in peripheral blood reflect levels in intracardiac blood in patients with atrial fibrillation secondary to mitral stenosis.
Topics: Atrial Fibrillation; beta-Thromboglobulin; Biomarkers; Blood Coagulation Factors; Blood Vessels; Catheterization; Female; Fibrin; Fibrinogen; Heart Atria; Heart Ventricles; Humans; Male; Middle Aged; Mitral Valve Stenosis; P-Selectin; Platelet Activation; Prognosis; Retrospective Studies; Risk Factors; Thrombophilia | 1999 |
Association of the alpha-fibrinogen Thr312Ala polymorphism with poststroke mortality in subjects with atrial fibrillation.
Topics: Amino Acid Substitution; Atrial Fibrillation; Brain Ischemia; Comorbidity; Coronary Disease; Diabetes Mellitus; Female; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Hypertension; Male; Point Mutation; Polymorphism, Genetic; Risk; Risk Factors; Smoking; Survival Analysis; Thromboembolism; Thrombophilia; Transglutaminases | 1999 |
Gender differences in blood thrombogenicity in hyperlipidemic patients and response to pravastatin.
Topics: Aged; Anticholesteremic Agents; Cholesterol, LDL; Female; Fibrinogen; Fibrinolysis; Humans; Hypercholesterolemia; Male; Middle Aged; Peptide Fragments; Plasminogen Activator Inhibitor 1; Platelet Aggregation; Pravastatin; Prothrombin; Sex Factors; Thrombin; Thrombophilia; Triglycerides | 1999 |
Resistance to activated protein C and low levels of free protein S in Greek patients with inflammatory bowel disease.
Topics: Activated Protein C Resistance; Adult; Antithrombin III; Female; Fibrinogen; Humans; Inflammatory Bowel Diseases; Male; Middle Aged; Protein C; Protein S; Thrombophilia | 2000 |
Familial thrombophilia and retinal vein occlusion.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Antiphospholipid; Biomarkers; Female; Fibrinogen; Homocysteine; Humans; Male; Middle Aged; Pilot Projects; Prospective Studies; Retinal Vein Occlusion; Risk Factors; Thrombophilia | 2000 |
Analysis of prothrombotic effects of two human monoclonal IgG antiphospholipid antibodies of apparently similar specificity.
Topics: Adenosine Diphosphate; Animals; Antibodies, Antiphospholipid; Antibodies, Monoclonal; Antibody Specificity; Antiphospholipid Syndrome; Autoimmune Diseases; Biomarkers; Blood Coagulation Factors; Blood Platelets; Cattle; Cells, Cultured; Dose-Response Relationship, Immunologic; Endothelium, Vascular; Female; Fibrinogen; Humans; Immunoglobulin G; Intracranial Embolism; Lipopolysaccharides; Lupus Erythematosus, Systemic; Male; Middle Aged; Monocytes; Peptide Fragments; Platelet Activation; Recurrence; Thrombophilia; Thromboplastin | 2000 |
Variations and clinical significance of coagulation and fibrinolysis parameters in patients with diabetes mellitus.
Topics: Adult; Aged; Antithrombin III; Blood Coagulation; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Thrombophilia | 1998 |
Association between blood rheology, thrombosis and cancer survival in patients with gynecologic malignancy.
Topics: Adult; Aged; Antineoplastic Agents; Blood Cell Count; Blood Viscosity; Breast Neoplasms; Carcinoma; Cell Hypoxia; Cohort Studies; Disease Progression; Erythrocyte Aggregation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Follow-Up Studies; Genital Neoplasms, Female; Germany; Hematocrit; Hemorheology; Humans; Life Tables; Microcirculation; Middle Aged; Neoplasm Metastasis; Neoplastic Cells, Circulating; Ovarian Neoplasms; Prospective Studies; Risk Factors; Survival Analysis; Thrombophilia; Uterine Cervical Neoplasms; Uterine Neoplasms; Venous Thrombosis | 2000 |
The effect of low-molecular weight dextran on erythrocyte aggregation in normal and preeclamptic pregnancy.
Topics: Adsorption; Dextrans; Erythrocyte Aggregation; Female; Fibrinogen; Hematocrit; Humans; Molecular Weight; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Hematologic; Thrombophilia | 2000 |
[Radiotherapy and coagulation system in women with cancer of the genital tract].
Topics: Adult; Aged; Antithrombin III; Blood Coagulation Disorders; Carcinoma; Female; Fibrinogen; Genital Neoplasms, Female; Humans; Middle Aged; Prothrombin; Radiation Dosage; Thrombophilia | 2000 |
Frequency of thrombophilic abnormalities in Turkish children with inflammatory bowel disease.
Topics: Adolescent; Antithrombin III; Biomarkers; Child; Female; Fibrinogen; Humans; Incidence; Inflammatory Bowel Diseases; Male; Protein C; Protein S; Thrombophilia; Turkey | 2000 |
Evidence of hypercoagulability in dogs with parvoviral enteritis.
Topics: Animals; Antifibrinolytic Agents; Antithrombin III; Case-Control Studies; Dog Diseases; Dogs; Enteritis; Enzyme-Linked Immunosorbent Assay; Fibrin Fibrinogen Degradation Products; Fibrinogen; Partial Thromboplastin Time; Parvoviridae Infections; Parvovirus, Canine; Platelet Count; Prothrombin Time; Thrombelastography; Thrombophilia | 2000 |
A global platelet test of thrombosis and thrombolysis detects a prothrombotic state in some patients with non-insulin dependent diabetes and in some patients with stroke.
Topics: Adult; Age Factors; Aged; Antifibrinolytic Agents; Arteriosclerosis; Diabetes Mellitus, Type 2; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinopeptide A; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Function Tests; Stress, Mechanical; Stroke; Thrombophilia | 2000 |
Prothrombotic changes in hemostatic parameters and C-reactive protein in the elderly with winter acute respiratory tract infections.
Topics: Acute Disease; Adult; Age Factors; Aged; Aged, 80 and over; C-Reactive Protein; Case-Control Studies; Cohort Studies; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Frail Elderly; Hemostatics; Humans; Male; Matched-Pair Analysis; Multivariate Analysis; Respiratory Tract Infections; Seasons; Sex Factors; Thrombophilia | 2001 |
Effect of high-dose progestogen on hemostatic properties of blood in patients with endometrial cancer.
Topics: Adult; Aged; alpha-2-Antiplasmin; Antifibrinolytic Agents; Antineoplastic Agents, Hormonal; Antithrombin III; Blood Coagulation; Blood Coagulation Tests; Blood Viscosity; Combined Modality Therapy; Endometrial Neoplasms; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Fibrinolysis; Hematocrit; Hemostasis; Humans; Hysterectomy; Medroxyprogesterone Acetate; Middle Aged; Partial Thromboplastin Time; Peptide Hydrolases; Platelet Count; Risk; Thrombophilia | 2001 |
Thrombophilic gene mutations and recurrent spontaneous abortion: prothrombin mutation increases the risk in the first trimester.
Topics: Abortion, Habitual; Adolescent; Adult; Antigens, CD; Factor V; Female; Fibrinogen; Germany; Humans; Integrin beta3; Methylenetetrahydrofolate Dehydrogenase (NAD+); Middle Aged; Mutation; Oxidoreductases; Platelet Membrane Glycoproteins; Polymorphism, Genetic; Pregnancy; Pregnancy Trimester, Third; Prevalence; Prothrombin; Risk Factors; Thrombophilia | 2001 |
Biochemical basis for the hypercoagulable state seen in Cushing syndrome; discussion 1006-7.
Topics: Animals; Antithrombin III; Blood Coagulation Factors; Cushing Syndrome; Dogs; Fibrinogen; Peptide Hydrolases; Thrombophilia | 2001 |
Relationship between fibrinogen protein and fibrinogen function in postmyocardial infarction patients.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Case-Control Studies; Female; Fibrinogen; Humans; Inflammation; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; N-Acetylneuraminic Acid; Recurrence; Retrospective Studies; Thrombophilia | 2001 |
Fibrinogen and thrombophilia.
Topics: Cardiovascular Diseases; Fibrinogen; Humans; Predictive Value of Tests; Risk Factors; Thrombophilia | 2001 |
Localization of blood coagulation factors in situ in pancreatic carcinoma.
Topics: Adenocarcinoma; Aged; Blood Coagulation Factors; Endothelium, Vascular; Female; Fibrin; Fibrinogen; Humans; Immunoenzyme Techniques; Male; Middle Aged; Neoplasm Proteins; Neoplastic Stem Cells; Pancreatic Neoplasms; Plasminogen Activator Inhibitor 1; Plasminogen Activator Inhibitor 2; Protein C; Protein S; Prothrombin; Stromal Cells; Thrombophilia; Thromboplastin | 2001 |
Reduced inhibition of activated prothrombin by heparin and venous thromboembolism: heparin resistance revisited.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Antithrombin III; Blood Coagulation Tests; Child; Drug Resistance; Female; Fibrinogen; Heparin; Humans; Male; Middle Aged; Prothrombin; Recurrence; Risk Factors; Thrombophilia; Venous Thrombosis | 2002 |
The concomitant appearance of aggregated erythrocytes, leukocytes and platelets in the peripheral blood of patients with risk factors for atherothrombosis.
Topics: Aged; Arteriosclerosis; Cell Adhesion; Cell Aggregation; Cholesterol; Cholesterol, LDL; Cohort Studies; Comorbidity; Computer Systems; Diabetes Mellitus; Erythrocyte Aggregation; Female; Fibrinogen; Hemorheology; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypertension; Inflammation; Israel; Leukocyte Count; Leukocytes; Male; Middle Aged; Platelet Aggregation; Risk Factors; Smoking; Thrombophilia; Triglycerides | 2001 |
Markers of inflammation and hypercoagulability in diabetic and nondiabetic patients with lower extremity ischemia.
Topics: Aged; Biomarkers; Blood Coagulation Factors; Blood Proteins; Case-Control Studies; Diabetes Complications; Diabetes Mellitus; Female; Fibrinogen; Humans; Inflammation; Ischemia; Lower Extremity; Male; Thrombophilia | 2002 |